Depression or dysthymia

F5_DEPRESSION_DYSTHYMIA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions not (F5_SCHIZO or F5_SCHIZOAFF or F5_BIPO	496819
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — F32, F33, F34.1 Hospital discharge: ICD-10 — F32, F33, F34.1 Hospital discharge: ICD-9 — 2961\|2968\|3004 Cause of death: ICD-10 — F32, F33 Cause of death: ICD-9 — 2961\|2968\|3004 3 out of 7 registries used, show all original rules.	81152
4. Check minimum number of events None	81152
5. Include endpoints None	81152
6. Filter based on genotype QC (FinnGen only)	77622

Control definitions (FinnGen only)

Control exclude: F5_PSYCH_INCLAVO, ANTIDEPRESSANTS

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF9

NAME	F5_DEPRESSION_DYSTHYMIA
CONTROL_EXCLUDE	F5_PSYCH_INCLAVO\|ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	!(F5_SCHIZO\|F5_SCHIZOAFF\|F5_BIPO)
OUTPAT_ICD	F3[2-3]\|F341
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F3[2-3]\|F341
HD_ICD_9	2961\|2968\|3004
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F3[2-3]
COD_ICD_9	2961\|2968\|3004
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Depression or dysthymia based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	77622	54766	22856
Unadjusted period prevalence (%)	16.79	19.43	10.47
Median age at first event (years)	44.87	43.02	49.32

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
44222: Matched controls
244025

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K07.60

ICD-10 Finland

Snapping jaw

3.0

321.6

1786

3411

R06AX27

ATC

desloratadine; oral

1.6

321.3

10637

40245

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

321.2

4622

13699

K59.09

ICD-10 Finland

Constipation, unspecified

2.7

320.4

2188

4694

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

4.3

318.1

1027

1329

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

317.7

3614

9804

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

+∞

317.3

389

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.6

316.8

2308

5120

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.4

316.7

1409

2334

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

314.5

4007

11355

N06BA12

ATC

lisdexamfetamine; oral

370.8

314.0

400

T74.1

ICD-10 Finland

Physical abuse

6.1

313.1

714

654

J01FA06

ATC

roxithromycin; oral

1.5

312.8

14532

59344

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

312.1

3521

9517

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

+∞

310.8

381

J45

ICD-10 Finland

Asthma

2.1

309.8

3709

10261

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

+∞

309.2

379

R41.3

ICD-10 Finland

Other amnesia

4.6

308.8

922

1113

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.5

308.8

2420

5566

A05

ICPC

Feeling ill

2.5

308.8

2288

5118

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

308.8

11127

42890

N05CD02

ATC

nitrazepam; oral

7.6

307.9

587

429

IHZ02, ,

SPAT

56.9

307.7

530

SPAT1216

SPAT

Assessment of functional ability

2.4

307.7

5399

13507

N06AA06

ATC

trimipramine; systemic

36.6

307.7

1314

204

N05BA12

ATC

alprazolam; oral

11.1

307.7

5804

3282

J01CA04

ATC

amoxicillin; systemic

1.6

307.7

33780

163375

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2798.9

307.7

507

N06AX12

ATC

bupropion; oral

114.5

307.7

6427

362

R42

ICD-10 Finland

Dizziness and giddiness

2.3

307.7

8975

24746

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

307.7

6970

19051

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

97.9

307.7

1542

S06.0

ICD-10 Finland

Concussion

2.8

307.7

4357

9258

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

+∞

307.7

399

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

+∞

307.7

882

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

307.7

10433

36700

N06CA01

ATC

amitriptyline and psycholeptics; systemic

6.4

307.7

5238

4988

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.3

307.7

1449

1546

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

307.7

11927

41022

F60.9

ICD-10 Finland

Personality disorder, unspecified

+∞

307.7

546

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

+∞

307.7

616

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.9

307.7

2419

4755

N05AX08

ATC

risperidone; systemic

28.6

307.7

2622

536

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

+∞

307.7

10722

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

+∞

307.7

947

V03AA01, ,

ATC

18.4

307.7

750

228

F41.1

ICD-10 Finland

Generalized anxiety disorder

+∞

307.7

3783

P01

ICPC

Feeling anxious/nervous/tense

16.3

307.7

8252

3393

M03BC51

ATC

orphenadrine, combinations; systemic

1.9

307.7

10604

34531

G04BD12

ATC

mirabegron; oral

2.1

307.7

3798

10377

N06AA09

ATC

amitriptyline; systemic

9.1

307.7

5031

3412

L28

ICPC

Limited function/disability (L)

2.5

307.7

6561

15714

N05BA02

ATC

chlordiazepoxide; systemic

23.6

307.7

1170

281

N05AX12

ATC

aripiprazole; systemic

870.2

307.7

913

N02BF02

ATC

pregabalin; oral

4.3

307.7

2560

3434

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

307.7

3005

7000

IHZ05, ,

SPAT

15.3

307.7

2069

780

Z29

ICPC

Social problem NOS

6.0

307.7

778

724

L03

ICPC

Low back symptom/complaint

2.2

307.7

11451

33420

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

+∞

307.7

7008

N03AE01

ATC

clonazepam; systemic

7.9

307.7

2689

1976

G47.3

ICD-10 Finland

Sleep apnoea

2.5

307.7

10337

26471

A02BA02

ATC

ranitidine; systemic

2.0

307.7

6945

20408

G47.9

ICD-10 Finland

Sleep disorder, unspecified

4.7

307.7

1042

1234

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

307.7

7450

20119

E0000UV, ,

ATC

1.6

307.7

15666

63789

R07.3

ICD-10 Finland

Other chest pain

2.3

307.7

3751

9608

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.8

307.7

3281

6718

F05.9

ICD-10 Finland

Delirium, unspecified

+∞

307.7

586

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.2

307.7

5778

15518

F45.8

ICD-10 Finland

Other somatoform disorders

+∞

307.7

2403

F51.0

ICD-10 Finland

Nonorganic insomnia

+∞

307.7

9460

N06AX18

ATC

reboxetine; oral

99.8

307.7

642

R52.9

ICD-10 Finland

Pain, unspecified

2.4

307.7

3803

9049

ZY010

NOMESCO Finland

Hospital outpatient

7.6

307.7

2475

1887

A04

ICPC

Weakness/tiredness general

3.3

307.7

6500

12140

L08

ICPC

Shoulder symptom/complaint

1.7

307.7

7894

27117

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

307.7

12991

50564

N03AX09

ATC

lamotrigine; oral

17.1

307.7

1780

598

J01EA01

ATC

trimethoprim; systemic

1.7

307.7

8923

31301

F41.3

ICD-10 Finland

Other mixed anxiety disorders

+∞

307.7

790

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.8

307.7

2985

6193

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

307.7

15925

48589

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

307.7

11141

34929

G44.2

ICD-10 Finland

Tension-type headache

2.9

307.7

5806

11959

N05CF01

ATC

zopiclone; oral

5.5

307.7

17040

24995

C07AA05

ATC

propranolol; systemic

3.8

307.7

9590

16513

E66.8

ICD-10 Finland

Other obesity

3.2

307.7

2170

3854

N06AX22

ATC

agomelatine; oral

270.4

307.7

1787

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

+∞

307.7

2060

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

393.6

307.7

771

F33

ICD-10 Finland

Recurrent depressive disorder

+∞

307.7

1896

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

307.7

17353

63100

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

6.5

307.7

739

635

F41.8

ICD-10 Finland

Other specified anxiety disorders

+∞

307.7

1675

H03AA01

ATC

levothyroxine sodium; systemic

1.9

307.7

8443

26991

M79.6

ICD-10 Finland

Pain in limb

2.0

307.7

17061

57661

J01CA08

ATC

pivmecillinam; oral

1.6

307.7

13827

53967

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

6.9

307.7

1488

1217

M48.0

ICD-10 Finland

Spinal stenosis

2.1

307.7

4194

11682

R06AE07

ATC

cetirizine; oral

1.7

307.7

17349

68069

F61.0

ICD-10 Finland

Mixed personality disorders

+∞

307.7

943

N06BA04

ATC

methylphenidate; oral

72.4

307.7

1656

131

Z2221

NOMESCO Finland

Medical doctor

1.6

307.7

9889

36399

P06

ICPC

Sleep disturbance

5.4

307.7

6029

6970

N05AF01

ATC

flupentixol; systemic

29.1

307.7

680

131

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

10.6

307.7

551

289

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.1

307.7

5815

8644

P99

ICPC

Psychological disorders other

32.6

307.7

1049

182

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.1

307.7

3385

6365

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

+∞

307.7

2660

N06AA22, ,

ATC

59.4

307.7

331

AA1AD

NOMESCO Finland

CT of head and brain

2.4

307.7

10584

28751

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.2

307.7

1643

2248

N06DA04

ATC

galantamine; oral

79.1

307.7

412

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.3

307.7

3321

8189

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

307.7

9749

35462

EBA00

NOMESCO Finland

Extraction of tooth

1.7

307.7

14205

52716

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

307.7

19403

73388

M70.6

ICD-10 Finland

Trochanteric bursitis

2.1

307.7

4431

12088

F39

ICD-10 Finland

Unspecified mood [affective] disorder

+∞

307.7

746

F60.5

ICD-10 Finland

Anankastic personality disorder

+∞

307.7

740

WX290

NOMESCO Finland

Other blockage of nerve

1.8

307.7

19325

74745

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

3.1

307.7

3801

7112

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

+∞

307.7

571

SPAT1283

SPAT

Restricted health certificate

2.1

307.7

7006

19957

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

+∞

307.7

1973

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

+∞

307.7

543

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

+∞

307.7

409

N02BF01

ATC

gabapentin; oral

3.0

307.7

3140

6074

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

307.7

10474

28519

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

161.1

307.7

859

R53

ICD-10 Finland

Malaise and fatigue

3.7

307.7

11562

21243

N17

ICPC

Vertigo/dizziness

2.1

307.7

4183

11371

F03

ICD-10 Finland

Unspecified dementia

+∞

307.7

925

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

307.7

9012

27185

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.3

307.7

3842

9754

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

+∞

307.7

865

N05AB03

ATC

perphenazine; systemic, rectal

53.7

307.7

1065

112

WZA10, ,

SPAT

30.8

307.7

508

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

307.7

18200

66283

M54.4

ICD-10 Finland

Lumbago with sciatica

2.4

307.7

7443

19041

J01DB01

ATC

cefalexin; oral

1.8

307.7

34555

162122

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

307.7

1253

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

307.7

11716

35396

H02AB06

ATC

prednisolone; systemic

1.6

307.7

18459

74645

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

307.7

13719

51955

P20

ICPC

Memory disturbance

4.2

307.7

4410

6274

IGY99

NOMESCO Finland

Other psychiatric treatment contact

113.7

307.7

869

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

+∞

307.7

5762

M25.5

ICD-10 Finland

Pain in joint

1.9

307.7

12686

42557

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

307.7

13916

54640

A28

ICPC

Limited function/disability NOS

2.4

307.7

5380

13528

XA800

NOMESCO Finland

Neuropsychological investigation

4.1

307.7

1725

2396

F43.2

ICD-10 Finland

Adjustment disorders

+∞

307.7

651

G30.8

ICD-10 Finland

Other Alzheimer disease

30.0

307.7

393

F33.8

ICD-10 Finland

Other recurrent depressive disorders

+∞

307.7

562

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

307.7

5646

15254

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

+∞

307.7

677

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

297.5

307.7

428

SPAT1312

SPAT

General health counselling

1.6

307.7

12064

46588

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

+∞

307.7

957

N05CF02

ATC

zolpidem; oral

5.4

307.7

8967

10941

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

307.7

9068

31324

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

+∞

307.7

769

Z01.2

ICD-10 Finland

Dental examination

1.6

307.7

18061

73484

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

20.5

307.7

384

104

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

+∞

307.7

4608

M79.1

ICD-10 Finland

Myalgia

2.2

307.7

5421

14271

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

307.7

27879

120908

R21

ICPC

Throat symptom/complaint

1.8

307.7

8113

26997

F10.20

ICD-10 Finland

Alcohol dependence currently independent

+∞

307.7

1151

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

+∞

307.7

3090

N05AL01

ATC

sulpiride; systemic

36.0

307.7

605

A02BC03

ATC

lansoprazole; oral

2.0

307.7

11122

35326

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

307.7

761

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.5

307.7

4676

11170

IGY02

NOMESCO Finland

Psychiatric monitoring contact

76.9

307.7

1272

SPAT1260

SPAT

Consultation of another employee

1.9

307.7

6435

20454

N05BE01

ATC

buspirone; oral

56.2

307.7

1753

179

30041

ICD-8 Finland

Neuroses, Depressiva

+∞

307.7

431

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

+∞

307.7

7730

Z3231

NOMESCO Finland

Registered nurse

1.9

307.7

10541

35222

N05BA04

ATC

oxazepam; oral

11.9

307.7

16619

11751

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

307.7

5563

16632

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.3

307.7

4488

11432

SFA30

NOMESCO Finland

Three-surface restoration

1.6

307.7

16144

64748

F32

ICD-10 Finland

Depressive episode

+∞

307.7

6860

F32.8

ICD-10 Finland

Other depressive episodes

+∞

307.7

1366

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

+∞

307.7

2271

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

+∞

307.7

860

N07BA03

ATC

varenicline; oral

3.2

307.7

1791

3206

Z72.1

ICD-10 Finland

Alcohol use

16.6

307.7

603

203

N06AA10

ATC

nortriptyline; systemic

10.5

307.7

915

491

C07AB07

ATC

bisoprolol; oral

1.7

307.7

17567

69275

SPAT1310

SPAT

Counselling related to known health issue

1.7

307.7

12271

44018

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.1

307.7

2182

3991

N06DA02

ATC

donepezil; oral

42.1

307.7

1123

151

N02AX02

ATC

tramadol; systemic, rectal

2.1

307.7

18305

60657

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

+∞

307.7

890

R51.80

ICD-10 Finland

Headache

3.0

307.7

6843

14223

P27

ICPC

Fear of mental disorder

20.1

307.7

441

122

D11

ICPC

Diarrhoea

2.5

307.7

4658

10955

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

307.7

16289

65603

OAB93, ,

SPAT

5.0

307.7

2574

3009

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

+∞

307.7

544

-1, ,

NOMESCO Finland

1.6

307.7

12565

49360

M03BX02

ATC

tizanidine; oral

2.0

307.7

26142

103099

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

307.7

5152

15289

IBA03

NOMESCO Finland

Psychotherapy evaluation

526.2

307.7

472

F43.00

ICD-10 Finland

Acute stress reaction mild

+∞

307.7

1043

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.8

307.7

1909

2842

N05AH04

ATC

quetiapine; oral

42.6

307.7

12655

2275

IHZ04, ,

SPAT

27.8

307.7

464

IGY99, ,

SPAT

11.3

307.7

630

312

P03

ICPC

Feeling depressed

36.1

307.7

8986

1711

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

307.7

8854

27955

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

+∞

307.7

1354

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

38.4

307.7

482

N01

ICPC

Headache

2.6

307.7

4529

10088

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

307.7

3327

8218

P25

ICPC

Phase of life problem adult

8.6

307.7

2206

1474

N06AA12

ATC

doxepin; systemic

22.0

307.7

2958

794

IGY02, ,

SPAT

60.0

307.7

399

N06AX17

ATC

milnacipran; oral

126.1

307.7

631

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

1962.3

307.7

711

M01AB05

ATC

diclofenac; systemic, rectal

1.6

307.7

26383

116231

N07BB01

ATC

disulfiram; oral

24.1

307.7

2487

603

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.5

307.7

5382

12910

Z73.0

ICD-10 Finland

Burn-out

21.1

307.7

2010

550

J02AC01

ATC

fluconazole; systemic

1.7

307.7

14618

54185

G43.9

ICD-10 Finland

Migraine, unspecified

3.2

307.7

2209

3891

R02

ICPC

Shortness of breath/dyspnoea

2.2

307.7

4790

12722

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

27.1

307.7

543

112

M03BC01

ATC

orphenadrine (citrate); systemic

2.1

307.7

8971

26810

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

67.0

307.7

1974

170

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

6.3

307.7

1218

1091

R52.2

ICD-10 Finland

Other chronic pain

5.3

307.7

1545

1671

N06AG02

ATC

moclobemide; oral

42.7

307.7

2972

411

N04BC05

ATC

pramipexole; oral

3.2

307.7

2857

5189

SPAT1243

SPAT

Psychiatric/psychological examination

30.2

307.7

1463

276

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1034.6

307.7

1130

Z08

ICPC

Social welfare problem

11.8

307.7

556

264

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

+∞

307.7

1149

KMAK, ,

NOMESCO Finland

1.6

307.7

20084

83818

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.6

307.7

3950

8815

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

307.7

11918

40185

Z2446

NOMESCO Finland

Social worker

4.0

307.7

2688

3910

N05AA02

ATC

levomepromazine; systemic

28.0

307.7

1520

310

J01DA01

ATC

[U] cefalexin

1.5

307.7

24254

107305

P16

ICPC

Acute alcohol abuse

22.1

307.7

783

199

SPAT1238

SPAT

Brief therapy

18.8

307.7

1041

313

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

+∞

307.7

3969

M54.2

ICD-10 Finland

Cervicalgia

2.4

307.7

2873

6792

N05AN01

ATC

lithium; oral

55.4

307.7

398

A02BC05

ATC

esomeprazole; systemic

2.0

307.7

16467

56649

SPAT1240

SPAT

Therapeutic discussion

12.8

307.7

7272

3708

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.2

307.7

4933

13054

SPAT1254

SPAT

Administration of medicine

2.3

307.7

5491

14022

R01AD09

ATC

mometasone; nasal

1.6

307.7

17729

71211

R05

ICPC

Cough

1.8

307.7

8972

30501

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

+∞

307.7

672

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.2

307.7

4895

13027

SPAT1307

SPAT

Psychosocial counselling and guidance

8.8

307.7

3390

2291

P02

ICPC

Acute stress reaction

7.2

307.7

2223

1776

S18

ICPC

Laceration/cut

1.6

307.7

17137

70404

L17

ICPC

Foot/toe symptom/complaint

1.8

307.7

10889

36994

N05AH03

ATC

olanzapine; systemic

33.7

307.7

1971

337

F41.09

ICD-10 Finland

UNS Panic Syndrome

+∞

307.7

1516

N30.0

ICD-10 Finland

Acute cystitis

2.0

307.7

5640

16509

N05AB01

ATC

dixyrazine; systemic

25.5

307.7

521

114

K02.1

ICD-10 Finland

Caries of dentine

1.8

307.7

24776

101310

SPAT1246

SPAT

Screening of depression or other psychiatric problem

4.1

307.7

1916

2677

F34.1

ICD-10 Finland

Dysthymia

+∞

307.7

3947

N06AX21

ATC

duloxetine; oral

26.7

307.7

8957

2296

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

307.7

4389

12271

F41.00

ICD-10 Finland

Moderate panic disorder

+∞

307.7

835

M01AC06

ATC

meloxicam; systemic, rectal

1.6

307.7

12939

51188

SPAT1265

SPAT

Breathalyser

20.4

307.7

385

105

UJF32

NOMESCO Finland

Coloscopy

1.7

307.7

9603

33601

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

307.7

7176

23565

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.5

307.7

2441

3955

ZYC02, ,

SPAT

5.0

307.7

1037

1171

N06AX03

ATC

mianserin; oral

43.8

307.7

3230

438

SPAT1263

SPAT

Sampling

1.7

307.7

16537

63581

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

5.7

307.7

4035

4257

M01AE02

ATC

naproxen; oral, rectal

1.7

307.7

22777

94982

N06AB10

ATC

escitalopram; oral

66.3

307.7

18397

2594

F41

ICD-10 Finland

Other anxiety disorders

+∞

307.7

747

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

307.7

9389

30535

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

307.7

30198

129275

Z2445

NOMESCO Finland

Psychologist

9.4

307.7

1945

1183

R06.0

ICD-10 Finland

Dyspnoea

2.1

307.7

10633

31431

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

307.7

8142

27487

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

307.7

1748

SAA01

NOMESCO Finland

Simple examination of mouth

2.0

307.7

30821

130130

N03AF01

ATC

carbamazepine; oral, rectal

3.3

307.7

1663

2896

M54.5

ICD-10 Finland

Low back pain

2.4

307.7

15808

46276

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

687.3

307.7

1329

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.8

307.7

2086

4294

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

+∞

307.7

2896

M01AH05

ATC

etoricoxib; oral

1.6

307.7

24310

106209

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

22.9

307.7

577

141

F99

ICD-10 Finland

Mental disorder, not otherwise specified

+∞

307.7

972

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.9

307.7

2817

5550

N06AB04

ATC

citalopram; systemic

37.5

307.7

16267

3729

SFA20

NOMESCO Finland

Two-surface restoration

1.7

307.7

23937

100646

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

307.7

15256

58676

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

150.0

307.7

801

N03AX12

ATC

[U] gabapentin; oral

3.4

307.7

7496

13935

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

215.1

307.7

1028

J01AA02

ATC

doxycycline; systemic

1.6

307.7

30940

143672

P29

ICPC

Psychological sympt/compl other

15.3

307.7

3870

1521

N02AA05

ATC

oxycodone; systemic

1.9

307.7

5818

17903

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

307.7

10089

37049

N06AB05

ATC

paroxetine; oral

39.2

307.7

3802

584

A02BC01

ATC

omeprazole; systemic

2.0

307.7

10582

33777

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

307.7

529

N06AB06

ATC

sertraline; oral

66.6

307.7

8912

921

K59.0

ICD-10 Finland

Constipation

3.0

307.7

1954

3762

A02BC02

ATC

pantoprazole; systemic

2.2

307.7

28552

111491

F10.25

ICD-10 Finland

Alcohol dependence continuous use

+∞

307.7

891

F32.0

ICD-10 Finland

Mild depressive episode

+∞

307.7

3058

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

307.7

11838

37835

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

+∞

307.7

1156

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

+∞

307.7

528

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.3

307.7

1751

3013

SFA10

NOMESCO Finland

One-surface restoration

1.7

307.7

22544

92347

SPAT1053

SPAT

Memory test

2.4

307.7

4310

10461

F43.8

ICD-10 Finland

Other reactions to severe stress

+∞

307.7

1110

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

307.7

6677

21881

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

+∞

307.7

455

L02

ICPC

Back symptom/complaint

2.4

307.7

3811

9159

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.9

307.7

3482

6918

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.9

307.7

1989

3876

F43.0

ICD-10 Finland

Acute stress reaction

+∞

307.7

2208

F10.09

ICD-10 Finland

Alcohol intoxication UNS

+∞

307.7

978

M54

ICD-10 Finland

Dorsalgia

2.2

307.7

4794

12798

M79.0

ICD-10 Finland

Rheumatism, unspecified

8.3

307.7

1629

1119

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

225.7

307.7

882

K30

ICD-10 Finland

Functional dyspepsia

2.2

307.7

4125

11007

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

25.5

307.7

422

F06.7

ICD-10 Finland

Mild cognitive disorder

+∞

307.7

810

L12

ICPC

Hand/finger symptom/complaint

1.9

307.7

5875

18572

N05BA06

ATC

lorazepam; systemic, sublingual

7.7

307.7

1992

1482

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

307.7

17655

67442

T36

ICD-10 Finland

Poisoning by systemic antibiotics

39.9

307.7

2596

381

A06AD11

ATC

lactulose; oral

2.6

307.7

5288

11901

N05BA01

ATC

diazepam; systemic, rectal

6.3

307.7

6847

6860

N06AX16

ATC

venlafaxine; oral

71.5

307.7

12775

1378

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

+∞

307.7

581

Z02.7

ICD-10 Finland

Issue of medical certificate

2.7

307.7

2702

5694

OAB38, ,

SPAT

8.6

307.7

749

487

F43

ICD-10 Finland

Reaction to severe stress, and adjustment disorders

+∞

307.7

700

G30.1

ICD-10 Finland

Alzheimer disease with late onset

20.6

307.7

1191

327

E66.01

ICD-10 Finland

Obesity due to excess calories

2.6

307.7

3494

7730

F40.1

ICD-10 Finland

Social phobias

+∞

307.7

1541

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.1

307.7

4818

13174

N06AB08

ATC

fluvoxamine; oral

47.3

307.7

1565

189

F43.1

ICD-10 Finland

Post-traumatic stress disorder

+∞

307.7

1400

N06DA03

ATC

rivastigmine; oral, transdermal

68.2

307.7

896

D01

ICPC

Abdominal pain/cramps general

2.3

307.7

4490

11608

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

307.7

17303

62635

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

307.7

20237

78036

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

17.0

307.7

6488

2448

P74

ICPC

Anxiety disorder/anxiety state

45.0

307.7

2554

332

F32.9

ICD-10 Finland

Depressive episode, unspecified

+∞

307.7

18324

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

+∞

307.7

483

R5140

NOMESCO Finland

Monitoring the use of the aid

2.3

307.7

4445

11131

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.2

307.7

9238

26469

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

+∞

307.7

4103

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.7

307.7

2496

3060

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

307.7

20587

88176

R74

ICPC

Upper respiratory infection acute

1.9

307.7

13004

43754

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

307.7

11329

34022

N06AX26

ATC

vortioxetine; oral

323.6

307.7

7136

145

L01

ICPC

Neck symptom/complaint

2.3

307.7

6185

15954

N03AX11

ATC

topiramate; oral

6.2

307.7

853

768

N06AX05

ATC

trazodone; oral

85.9

307.7

1591

106

Z05

ICPC

Work problem

6.6

307.7

1156

986

M79.7

ICD-10 Finland

Fibromyalgia

10.6

307.7

1721

930

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

307.7

4894

14433

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

307.7

23017

90761

N06AA04

ATC

clomipramine; systemic

41.4

307.7

818

111

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

307.7

2659

5888

SPAT1301

SPAT

No procedures

1.8

307.7

11837

41561

Z71.8

ICD-10 Finland

Other specified counselling

1.9

307.7

12280

40825

P15

ICPC

Chronic alcohol abuse

32.9

307.7

1638

285

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

307.7

9290

32745

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

307.7

15147

61028

P76

ICPC

Depressive disorder

143.6

307.7

6242

279

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

+∞

307.7

7091

F90.0

ICD-10 Finland

Disturbance of activity and attention

+∞

307.7

1859

R03AC02

ATC

salbutamol; inhalant

2.0

307.7

23035

87130

OAA65, ,

SPAT

2.7

307.7

6696

15057

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

307.7

7328

20887

SPAT1241

SPAT

Extensive assessment of psychosocial situation

24.0

307.7

529

123

F10.24

ICD-10 Finland

Alcohol depence active use

+∞

307.7

801

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.9

307.7

1973

3847

A01

ICPC

Pain general/multiple sites

3.1

307.7

3633

6876

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

+∞

307.7

484

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.5

307.7

3593

8396

N06DX01

ATC

memantine; oral

65.7

307.7

1529

133

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

8.9

307.7

608

380

F32.1

ICD-10 Finland

Moderate depressive episode

+∞

307.7

7033

N06AB03

ATC

fluoxetine; oral

31.4

307.7

8807

1917

F51

ICD-10 Finland

Nonorganic sleep disorders

+∞

307.7

1773

F43.01

ICD-10 Finland

Acute stress reaction moderate

+∞

307.7

647

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

+∞

307.7

5065

P01AB01

ATC

metronidazole; oral, rectal

1.8

307.7

15474

57358

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

224.9

307.7

1986

N03AX16

ATC

[U] pregabalin

3.4

307.7

11125

22154

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

36.7

307.7

1272

197

N03AG01

ATC

valproic acid; systemic, rectal

6.7

307.7

1765

1515

R11

ICD-10 Finland

Nausea and vomiting

2.8

307.7

3320

6795

SPAT1284

SPAT

Extensive health certificate

4.6

307.7

1134

1374

SPAT1234

SPAT

Support of social functional capacity

5.2

307.7

1783

1966

F43.29

ICD-10 Finland

Adaptation disorder UNS

+∞

307.7

1054

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

307.7

7083

21233

ZY000

NOMESCO Finland

Hospital inpatient

22.5

307.7

404

100

F52.2

ICD-10 Finland

Failure of genital response

+∞

307.7

446

Z3226

NOMESCO Finland

Physiotherapist

1.9

307.7

6616

20292

A03CA02

ATC

clidinium and psycholeptics; oral

3.0

307.7

2046

3880

N05AF03

ATC

chlorprothixene; systemic

128.7

307.7

734

N05CD07

ATC

temazepam; oral

6.9

307.7

5696

5154

R51

ICD-10 Finland

Headache

2.9

307.7

2057

4095

P58

ICPC

Psychological, Therapeutic counselling/listening

14.1

307.7

932

371

N06AX11

ATC

mirtazapine; oral

24.1

307.7

24801

12273

N02BE01

ATC

paracetamol; systemic, rectal

2.4

307.7

37805

174278

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

307.7

601

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.0

306.9

1631

3032

K59.1

ICD-10 Finland

Functional diarrhoea

2.8

306.3

1911

3902

D09

ICPC

Nausea

3.0

306.2

1645

3078

TAB00

NOMESCO Finland

Lumbar puncture

3.1

302.6

1539

2783

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

301.5

37768

189239

J01FF01

ATC

clindamycin; systemic

1.6

298.1

9885

37303

R03DC03

ATC

montelukast; oral

1.8

297.8

5821

19043

M01AH01

ATC

celecoxib; oral

1.8

297.0

6143

20438

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.6

296.9

2140

4718

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

296.7

5327

16973

R01AD08

ATC

fluticasone; nasal

1.6

296.4

10487

40181

R03BB04

ATC

tiotropium bromide; inhalant

2.1

295.8

3397

9239

R4110

NOMESCO Finland

Physiotherapy

1.6

295.6

9840

37156

T82

ICPC

Obesity

3.2

295.5

1456

2580

N05AD03

ATC

melperone; systemic

18.6

295.5

357

107

R41.0

ICD-10 Finland

Disorientation, unspecified

4.9

293.1

819

929

SPAT1229

SPAT

Assessment of need for aid

2.4

292.9

2403

5647

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

+∞

292.8

359

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

6.8

292.7

612

505

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

57.0

292.6

277

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

+∞

292.0

358

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

290.6

8259

29967

A03FA02

ATC

cisapride; oral, rectal

2.4

290.3

2557

6210

ZXE00

NOMESCO Finland

One hour or less

1.5

289.9

14205

58432

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

+∞

289.5

355

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

7.1

289.1

580

454

L86

ICPC

Back syndrome with radiating pain

2.5

287.9

2140

4791

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

286.9

4969

15639

IBA01, ,

SPAT

13.1

286.8

399

170

L15

ICPC

Knee symptom/complaint

1.6

286.0

8432

30866

ZYC01

NOMESCO Finland

Remote contact by phone

2.6

285.3

2059

4541

R03BA02

ATC

budesonide; inhalant

1.7

284.9

6360

21610

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

284.2

6965

24287

SPAT1389

SPAT

Visit based on need for special support

5.0

282.4

776

866

R01AD12

ATC

fluticasone furoate; nasal

1.5

280.5

11658

46222

D82

ICPC

Teeth/gum disease

1.5

280.4

13997

57700

SPAT1237

SPAT

Psychotherapy

27.4

279.1

301

Z00.0

ICD-10 Finland

General medical examination

1.7

278.2

6967

24421

W19

ICD-10 Finland

Unspecified fall

2.1

277.1

3362

9332

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.0

277.0

1490

2788

J01FA10

ATC

azithromycin; systemic

1.4

276.7

22399

101379

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.7

276.7

1868

3978

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

275.8

7679

27671

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

5.8

274.6

652

625

R4140

NOMESCO Finland

Psychotherapy

47.3

271.9

264

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

121.0

271.0

240

R00.2

ICD-10 Finland

Palpitations

2.2

270.6

2655

6758

AA400

NOMESCO Finland

Electroconvulsive therapy

475.1

270.4

342

IAA01, ,

SPAT

27.3

268.7

290

F50.9

ICD-10 Finland

Eating disorder, unspecified

+∞

268.3

329

R06.5

ICD-10 Finland

Mouth breathing

2.1

268.3

3266

9073

A02BA04

ATC

nizatidine; systemic

2.3

268.0

2529

6329

D10

ICPC

Vomiting

2.5

267.7

2040

4621

N05BA05

ATC

potassium clorazepate; oral

15.9

266.9

341

119

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.1

266.5

3160

8689

ZXD05

NOMESCO Finland

Urgent procedure

1.5

266.1

10971

43328

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

266.0

4777

15185

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

265.7

14727

61840

U02

ICPC

Urinary frequency/urgency

1.8

265.5

4603

14469

A03

ICPC

Fever

1.7

265.1

6188

21250

F60.8

ICD-10 Finland

Other specific personality disorders

+∞

265.0

325

D07AC01

ATC

betamethasone; topical

1.5

263.0

13094

53782

S01.0

ICD-10 Finland

Open wound of scalp

2.2

262.9

2597

6628

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.2

262.3

2771

7274

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

262.3

3867

11515

P70

ICPC

Dementia

13.4

262.2

360

149

Z12

ICPC

Relationship problem with partner

5.8

261.6

620

593

R55

ICD-10 Finland

Syncope and collapse

2.0

259.7

3637

10634

R01AD58

ATC

fluticasone, combinations; nasal

1.6

259.7

8849

33444

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

258.8

9285

35508

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

+∞

258.5

317

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

+∞

258.5

317

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

257.8

8683

32718

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

257.3

27167

128340

R96

ICPC

Asthma

2.0

257.2

3228

9067

SPAT1235

SPAT

Mental health, emotional support

28.7

256.9

274

M54.6

ICD-10 Finland

Pain in thoracic spine

2.2

255.6

2541

6500

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

+∞

255.2

313

SPAT1227

SPAT

Substance abuse rehabilitation

28.9

254.6

271

J20

ICD-10 Finland

Acute bronchitis

2.0

254.4

3553

10375

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

253.9

7102

25560

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

+∞

253.6

311

S29

ICPC

Skin symptom/complaint other

1.7

253.2

6645

23524

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.3

252.2

1192

2054

D06

ICPC

Abdominal pain localized other

2.1

251.8

3005

8277

IGP01

NOMESCO Finland

Psychiatric family contact

62.1

250.8

235

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

250.5

19136

85079

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

249.6

4466

14162

A11

ICPC

Chest pain NOS

2.1

249.6

2734

7279

SGA01

NOMESCO Finland

Emergency treatment

1.7

249.6

5927

20421

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

879.2

249.0

311

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

248.5

1454

2858

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.6

247.0

1721

3723

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.5

246.5

1038

1652

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

+∞

246.2

302

M01AX17

ATC

nimesulide; oral

1.6

245.6

7958

29669

OAB91, ,

SPAT

2.4

244.7

2042

4828

R13

ICD-10 Finland

Dysphagia

2.3

243.2

2223

5480

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

243.0

10443

41465

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

242.0

7307

26771

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

242.0

4746

15471

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

12.4

241.8

345

155

R52.1

ICD-10 Finland

Chronic intractable pain

10.2

241.7

381

207

U04

ICPC

Incontinence urine

2.8

241.7

1474

2966

E66

ICD-10 Finland

Obesity

2.5

240.6

1782

3976

R05

ICD-10 Finland

Cough

1.6

239.6

7383

27176

M02AA07

ATC

piroxicam; topical

1.5

239.1

12288

50580

R35

ICD-10 Finland

Polyuria

2.3

238.7

2220

5513

H01

ICPC

Ear pain/earache

1.8

238.3

4074

12724

SCA01

NOMESCO Finland

Preventive oral health care, short

1.5

237.7

10660

42672

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.6

237.6

7764

28975

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

+∞

237.3

291

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

+∞

236.4

290

R03AC03

ATC

terbutaline; inhalant

1.8

234.7

4790

15790

J01MA02

ATC

ciprofloxacin; systemic

1.4

233.9

13743

58000

N89

ICPC

Migraine

3.3

233.3

1097

1883

WYA10

NOMESCO Finland

Emergency care or similar visit

2.1

232.1

2612

7024

N03AF02

ATC

oxcarbazepine; oral

3.2

232.1

1102

1904

N76.0

ICD-10 Finland

Acute vaginitis

2.4

232.0

1919

4517

F41.01

ICD-10 Finland

Severe panic disorder

+∞

231.5

284

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

231.1

3044

8691

WX002

NOMESCO Finland

Sedation and analgesia

1.6

231.1

6478

23270

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

230.6

3106

8941

S22.3

ICD-10 Finland

Fracture of rib

2.2

230.4

2422

6335

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.1

230.4

2648

7180

N05CD08

ATC

midazolam; nasal, systemic

4.5

227.9

710

890

309

Kela drug reimbursment

Nalmefene and naltrexone

94.7

227.6

205

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

227.2

13391

56473

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

+∞

226.6

278

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.4

226.3

1942

4649

A97

ICPC

No disease

1.6

226.2

6221

22228

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

+∞

225.8

277

K04.0

ICD-10 Finland

Pulpitis

1.9

225.7

3281

9700

L13

ICPC

Hip symptom/complaint

1.7

225.1

5824

20483

SPAT1360

SPAT

Extensive global examination

2.2

225.0

2340

6092

OAA81, ,

SPAT

3.3

224.4

1035

1754

E66.00

ICD-10 Finland

Metabolic syndrome

2.3

222.3

1940

4679

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

222.2

21080

96562

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

221.9

4067

12967

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

221.7

8426

32480

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.8

221.3

1372

2785

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

220.9

4683

15589

R03BA01

ATC

beclometasone; inhalant

1.7

220.6

4756

15909

V03AB30, ,

ATC

16.0

219.8

280

R03BA05

ATC

fluticasone; inhalant

1.6

219.7

6299

22727

P81

ICPC

Hyperkinetic disorder

28.2

218.6

234

A06AC51

ATC

ispaghula, combinations; oral

2.6

218.2

1588

3510

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

10.4

217.9

341

183

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.9

217.5

3500

10703

K08.3

ICD-10 Finland

Retained dental root

2.1

217.4

2537

6916

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

216.5

2532

6908

A02BC04

ATC

rabeprazole; oral

2.0

215.8

2887

8283

G43.3

ICD-10 Finland

Complicated migraine

5.4

215.6

547

563

U01

ICPC

Dysuria/painful urination

2.1

215.3

2509

6835

A99

ICPC

Disease/condition unspecnature/site

2.0

214.4

3019

8821

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

214.1

9623

38396

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

6.1

214.0

484

439

SPAT1247

SPAT

Outpatient detoxication and monitoring

35.6

214.0

218

C03CA01

ATC

furosemide; systemic

1.5

213.5

9167

36229

G04BD04

ATC

oxybutynin; oral, transdermal

2.6

213.3

1540

3389

P48

ICPC

Psychological, Clarification/discussion RFE/demand

24.7

213.2

236

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

1435.3

212.9

264

A29

ICPC

General symptom/complaint other

1.8

212.7

3939

12590

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

212.5

1875

4544

M03BX01

ATC

baclofen; systemic

4.8

212.1

611

713

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.5

211.6

1658

3800

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

211.6

10265

41578

I95.1

ICD-10 Finland

Orthostatic hypotension

3.1

211.4

1079

1952

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

+∞

211.1

259

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

210.3

8294

32181

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

210.0

5398

18924

SPAT1281

SPAT

Other administrative function

2.0

209.0

2653

7463

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

208.8

1612

3668

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

208.5

5395

18943

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

208.4

7698

29436

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

11.4

207.7

309

151

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

207.6

2333

6263

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.1

207.5

1051

1892

R12

ICD-10 Finland

Heartburn

2.0

206.7

2692

7644

R1250

NOMESCO Finland

Evaluation of functional capability

3.9

206.1

754

1080

L16

ICPC

Ankle symptom/complaint

1.8

205.8

3858

12370

G43

ICD-10 Finland

Migraine

2.5

204.6

1578

3588

K08.80

ICD-10 Finland

Toothache NOS

1.9

204.6

2906

8512

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

20.6

204.1

238

SDA03

NOMESCO Finland

Periodontal treatment

1.4

203.1

14669

63838

E66.9

ICD-10 Finland

Obesity, unspecified

2.9

202.6

1181

2314

SPAT1058

SPAT

PEF monitoring instruction

2.0

202.0

2694

7714

G04BD08

ATC

solifenacin; oral

2.2

201.2

1967

4985

D19

ICPC

Teeth/gum symptom/complaint

1.5

201.1

10107

41151

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

53.2

201.0

192

SPAT1252

SPAT

Overall medication plan or its review

2.2

199.5

2003

5133

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

199.3

3559

11237

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

21.8

198.9

228

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

198.4

6721

25174

A01AB09

ATC

miconazole; local oral

2.0

197.7

2764

8048

G30

ICD-10 Finland

Alzheimer disease

50.1

197.4

190

X58

ICD-10 Finland

Exposure to other specified factors

1.7

197.1

5028

17569

F84.5

ICD-10 Finland

Asperger syndrome

+∞

196.4

241

K10.3

ICD-10 Finland

Alveolitis of jaws

2.4

196.4

1555

3580

K05.31

ICD-10 Finland

Periodontitis pronounced

1.8

195.6

3536

11204

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

194.9

3380

10572

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

+∞

194.8

239

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

194.8

3786

12262

T90

ICPC

Diabetes non-insulin dependent

1.5

194.2

7704

29862

M54.1

ICD-10 Finland

Radiculopathy

2.6

193.7

1337

2874

R83

ICPC

Respiratory infection other

1.5

193.0

9278

37398

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

192.5

5900

21572

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

191.9

13650

59100

M54.8

ICD-10 Finland

Other dorsalgia

2.5

191.8

1473

3341

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

+∞

191.5

235

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

+∞

191.5

235

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

191.5

3989

13181

P28

ICPC

Limited function/disability (P)

24.1

191.2

213

M54.3

ICD-10 Finland

Sciatica

2.2

191.1

1949

5026

F01.9

ICD-10 Finland

Vascular dementia, unspecified

+∞

190.7

234

R50.9

ICD-10 Finland

Fever, unspecified

1.6

190.7

4994

17559

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.4

189.7

1570

3691

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

189.6

4114

13751

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

189.6

1153

2314

D02

ICPC

Abdominal pain epigastric

2.2

189.5

2025

5323

P18

ICPC

Medication abuse

32.1

189.5

197

Z63.5

ICD-10 Finland

Disruption of family by separation and divorce

32.1

189.5

197

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.6

189.0

1292

2763

P19

ICPC

Drug abuse

12.0

188.9

273

126

K04.08

ICD-10 Finland

Other specified pulpit

2.0

188.1

2546

7324

IHZ01, ,

SPAT

8.3

188.1

338

227

R07.0

ICD-10 Finland

Pain in throat

2.0

187.7

2365

6628

H02AB04

ATC

methylprednisolone; systemic

1.6

187.7

4816

16840

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

187.4

2279

6302

H02AB07

ATC

prednisone; oral

1.7

187.3

4566

15752

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002385) Erythrocyte distribution width [Ratio]

33911

164737

1.58

321.07

18.4

14.0

14.92

14.93

0.05

33340

161644

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6154

20156

1.80

315.11

5.9

6.6

1.04

mmol/l

1.06

5737

18936

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

8890

32443

1.64

308.32

1.6

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

8683

24863

2.15

307.65

2.8

3.4

2.44

2.45

mmol/l

13.82

7546

21829

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

8415

15468

3.47

307.65

2.0

1.3

1.55

1.28

129.42

7279

13950

(3001122) Ferritin [Mass/volume] in Serum or Plasma

20730

69553

2.21

307.65

3.1

2.7

115.33

136.31

ug/l

15.47

19093

65042

(3001604) Monocytes [#/volume] in Blood

21993

85284

1.84

307.65

5.8

0.58

e9/l

1.99

19006

74284

(3020191) Ethanol [Moles/volume] in Serum or Plasma

706

537

7.36

307.65

1.5

1.1

1.69

0.79

promille

26.03

533

425

(3002030) Lymphocytes/100 leukocytes in Blood

21033

83949

1.73

307.65

6.1

6.0

28.35

28.06

3.16

19650

79364

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

37621

177086

2.15

307.65

4.8

4.1

5.97

5.87

mmol/l

31.01

34370

162797

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4535

13091

2.02

307.65

2.5

2.0

13.09

12.45

nmol/l

5.24

4007

11956

(3007164) IgA [Mass/volume] in Serum or Plasma

9815

30851

1.97

307.65

1.5

1.4

2.40

2.41

g/l

0.13

5744

19620

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4770

13931

2.00

307.65

2.8

2.4

44.57

50.18

u/l

0.20

4026

12092

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

12004

36849

2.09

307.65

2.4

2.2

2.89

2.98

mg/l

3.03

10207

31826

(3026008) Bacteria identified in Urine by Culture

12804

46418

1.73

307.65

3.3

2.7

—

(3006315) Basophils [#/volume] in Blood

22062

85475

1.85

307.65

5.8

0.04

e9/l

4.13

19057

74408

(3002582) Erythrocytes [#/volume] in Urine

13289

49603

1.68

307.65

3.5

3.1

68.40

99.18

e6/l

1.54

10142

37922

(3022948) Iron [Moles/volume] in Serum or Plasma

7479

24721

1.81

307.65

2.5

2.6

13.45

13.32

umol/l

0.73

6878

23350

(3013707) Erythrocyte sedimentation rate by Westergren method

31651

127112

2.32

307.65

4.4

3.8

11.45

11.72

mm/h

2.48

29308

118114

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

20210

68722

2.15

307.65

6.1

6.2

1.21

mmol/l

2.00

18439

62936

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6626

19165

2.07

307.65

2.3

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

16519

59495

1.85

307.65

4.0

3.1

56.57

59.71

ng/l

0.11

10819

39644

(3031040) Bacteria [#/volume] in Urine by Automated count

27614

111929

1.96

307.65

5.0

3.7

1122.70

943.94

e6/l

0.22

349

1516

(3018095) Leukocytes [#/volume] in Urine

15387

58597

1.69

307.65

4.0

3.5

70.50

92.99

e6/l

3.75

10889

40954

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

35826

166160

2.00

307.65

6.1

5.1

39.72

39.48

mmol/mol

4.42

33139

154695

(40758558) Short blood count panel - Blood

11177

41886

1.63

307.65

6.0

6.9

—

(3044889) 12 lead EKG panel

27757

121619

1.70

307.65

3.9

3.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

22969

84665

2.03

307.65

6.0

6.5

10.81

11.85

umol/l

26.50

21596

80781

(3035941) MCH [Entitic mass]

42076

217432

2.40

307.65

23.7

16.7

30.31

30.22

21.19

41543

214318

(40761511) CBC panel - Blood by Automated count

40279

198528

2.34

307.65

15.3

10.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

11346

34781

2.08

307.65

1.3

1.43

2.04

u/ml

4.65

3021

9614

(3011288) Drugs identified in Urine by Screen method

2325

2119

6.34

307.65

3.3

1.2

—

(36304419) Bacteria [Presence] in Urine

12128

43666

1.73

307.65

3.3

2.9

—

(3016879) Cocaine [Presence] in Urine

2703

4490

3.47

307.65

2.4

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

6099

16995

2.14

307.65

2.2

1.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

19153

63377

2.18

307.65

2.4

2.2

4846.30

77.51

nmol/l

0.50

17189

57487

(3037522) Nuclear Ab [Titer] in Serum

6671

22223

1.77

307.65

1.4

1.3

463.27

582.49

titre

5.49

1327

4671

(3048689) Calprotectin [Mass/mass] in Stool

6609

18767

2.11

307.65

2.3

2.6

126.77

147.00

ug/g

2.97

5140

15252

(3010813) Leukocytes [#/volume] in Blood

42083

217523

2.40

307.65

23.8

16.7

6.81

6.64

e9/l

35.44

41065

210591

(3013115) Eosinophils [#/volume] in Blood

22686

88380

1.86

307.65

5.9

0.20

0.19

e9/l

0.92

19925

77911

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10098

35115

1.76

307.65

1.8

1.04

1.31

mg/l

12.47

7482

27056

(3035350) Ketones [Presence] in Urine by Test strip

20626

85164

1.63

307.65

4.0

3.2

0.00

estimate

0.74

4439

16462

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11604

44428

1.60

307.65

3.1

3.0

1152.43

1424.46

ng/l

8.65

9621

38403

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

19317

58829

2.44

307.65

2.1

1.8

96.82

95.78

pmol/l

1.93

10301

30931

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15332

53563

1.89

307.65

3.4

3.1

34.07

34.02

u/l

0.01

14405

51124

(3013650) Neutrophils [#/volume] in Blood by Automated count

24625

99414

1.83

307.65

7.9

8.7

4.13

4.05

e9/l

5.43

21457

86931

(3022096) Basophils/100 leukocytes in Blood

19763

78138

1.72

307.65

6.1

6.0

0.69

0.68

1.69

18337

73403

(3037467) Urinalysis macro (dipstick) panel - Urine

28581

120712

1.87

307.65

4.7

3.8

—

(3033658) Prothrombin time (PT) actual/Normal

11364

42438

1.64

307.65

4.3

3.8

92.03

89.59

18.92

11046

41516

(3009261) Glucose [Presence] in Urine by Test strip

20716

86338

1.61

307.65

4.0

3.2

0.00

estimate

0.36

4155

15172

(3009508) Creatinine [Moles/volume] in Urine

13467

53006

1.58

307.65

3.3

3.2

7.89

mmol/l

0.01

11330

45235

(3006504) Eosinophils/100 leukocytes in Blood

20422

80704

1.74

307.65

6.0

2.88

2.89

0.41

19019

75987

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

29433

119558

2.07

307.65

3.7

2.6

51.81

45.39

u/l

20.66

27432

112514

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

34130

127974

3.07

307.65

4.4

3.5

14.57

14.84

pmol/l

67.04

31140

116294

(3015736) pH of Urine

17208

67402

1.67

307.65

3.6

3.0

5.90

5.83

1.61

1179

5629

(3021601) Nitrite [Presence] in Urine by Test strip

20580

85378

1.62

307.65

5.2

4.4

0.00

estimate

0.17

4304

15629

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

32569

130997

2.41

307.65

7.9

7.5

77.10

78.39

u/l

5.02

30661

123930

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

40946

202482

2.56

307.65

11.7

9.1

27.68

26.64

u/l

15.44

39612

195482

(3028300) Cannabinoids [Presence] in Urine

2847

5160

3.19

307.65

2.4

1.2

—

(3027008) Opiates [Presence] in Urine

2829

5155

3.17

307.65

2.2

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

568

64.79

307.65

2.1

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

42083

217622

2.39

307.65

24.0

16.8

135.91

136.88

g/l

33.90

41544

214504

(3019550) Sodium [Moles/volume] in Serum or Plasma

40173

187659

2.98

307.65

18.4

13.5

139.53

139.75

mmol/l

58.60

39236

182517

(3018010) Neutrophils/100 leukocytes in Blood

20722

82587

1.72

307.65

5.9

5.8

56.86

57.09

1.86

19354

78026

(3022217) INR in Platelet poor plasma by Coagulation assay

19401

76591

1.71

307.65

14.1

14.2

1.21

1.29

inr

12.49

5810

22011

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

8226

27805

1.78

307.65

1.3

1.2

31.25

38.53

iu/ml

2.60

2408

9373

(3000764) Benzodiazepines [Presence] in Urine

2831

5074

3.22

307.65

2.4

1.2

—

(3007461) Platelets [#/volume] in Blood

42069

217167

2.42

307.65

23.9

16.8

256.05

249.17

e9/l

83.75

41160

210912

(3000850) Epithelial cells [#/volume] in Urine

9435

33684

1.69

307.65

2.8

2.5

5.74

4.99

e6/l

5.29

8442

30174

(3024731) MCV [Entitic volume]

42076

217470

2.39

307.65

23.8

16.7

90.90

90.59

35.17

41539

214336

(40768797) Stomach Pathology biopsy report

6844

20965

1.95

307.65

1.3

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

20750

80205

1.81

307.65

6.3

6.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5442

11925

2.73

307.65

2.1

2.5

366.53

378.26

nmol/l

3.31

4907

11167

(3036180) Methadone [Presence] in Urine

412

112

20.48

307.65

2.7

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7714

24495

1.89

307.65

3.4

3.7

0.81

0.82

mmol/l

9.48

7165

23158

(3027944) Amphetamines [Presence] in Urine

2767

5146

3.10

307.65

2.2

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

12370

45024

1.72

307.65

3.3

3.0

0.38

0.41

e6/l

0.76

9383

34048

(3026782) Osmolality of Urine

8878

32004

1.66

307.65

3.0

2.8

529.63

561.73

mosm/kgh2o

29.74

7603

27669

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

14950

48768

2.04

307.65

2.8

2.5

57.17

63.25

u/l

4.00

13731

45409

(3026361) Erythrocytes [#/volume] in Blood

42079

217498

2.39

307.65

23.8

16.7

4.51

4.55

e12/l

49.37

41048

210599

(3015377) Calcium [Moles/volume] in Serum or Plasma

15659

48499

2.21

307.65

3.0

3.8

2.35

mmol/l

1.47

13684

42988

(3024561) Albumin [Mass/volume] in Serum or Plasma

19406

67253

2.06

307.65

4.8

5.1

35.97

35.55

g/l

19.32

17985

62937

(3019309) Folate [Moles/volume] in Red Blood Cells

9563

22290

2.74

307.65

1.8

1.7

1173.00

1130.75

nmol/l

3.70

7187

16871

(3021960) Folate [Moles/volume] in Serum or Plasma

11516

29679

2.54

307.65

1.6

1.5

20.41

20.10

nmol/l

1.19

9916

25384

(3021589) Normoblasts [#/volume] in Blood

18985

78125

1.60

307.65

9.9

8.9

0.00

e9/l

1.42

15516

64697

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

21912

76361

2.16

307.65

6.7

7.0

1.21

mmol/l

0.83

18516

65225

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7707

26140

1.76

307.65

1.3

1.2

9.58

14.32

u/ml

6.15

2879

10392

(3023368) Bacteria identified in Blood by Culture

11516

42394

1.67

307.65

4.6

4.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

36943

175032

2.00

307.65

14.6

11.4

85.13

82.12

ml/min/173m2

117.72

30776

142998

(3013826) Glucose [Moles/volume] in Serum or Plasma

24919

98615

1.90

307.65

5.2

4.4

6.67

6.72

mmol/l

3.26

23374

91078

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1448

1744

4.70

307.65

1.4

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

10062

29318

2.16

307.65

1.7

1.6

33787802.21

45749889.18

pmol/l

0.97

8296

24444

(3009542) Hematocrit [Volume Fraction] of Blood

42047

216917

2.42

307.65

23.9

16.9

40.52

40.87

1.67

39911

203386

(3020564) Creatinine [Moles/volume] in Serum or Plasma

40728

201154

2.48

307.65

18.3

13.9

76.13

78.09

umol/l

25.25

40719

201044

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

27229

124679

1.53

307.65

3.4

2.8

—

(3019198) Lymphocytes [#/volume] in Blood

22567

88212

1.84

307.65

5.8

1.96

1.92

e9/l

1.38

19979

78519

(3019069) Monocytes/100 leukocytes in Blood

20525

81180

1.74

307.65

6.3

8.44

8.64

14.69

19147

76534

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

39508

186697

2.57

307.65

16.6

11.7

21.32

24.61

mg/l

66.61

32317

143093

(3023103) Potassium [Moles/volume] in Serum or Plasma

40225

188353

2.97

307.65

18.5

13.6

3.95

3.97

mmol/l

39.64

39225

182786

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6845

22848

1.77

307.65

2.5

2.6

2.38

2.32

g/l

11.32

6213

21431

(3028707) Methadone [Presence] in Urine by Screen method

1755

335

30.06

307.65

2.7

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2384

3204

4.28

307.65

2.5

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7151

23544

1.81

307.65

1.9

1.7

—

(3018418) pH of Serum or Plasma

13355

43859

1.97

307.65

4.2

4.4

7.40

0.88

2637

8324

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

14096

44999

2.07

307.65

2.3

1.9

206.36

195.15

u/l

0.39

13217

42186

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

38333

161259

3.34

307.65

5.4

4.0

1.96

2.19

mu/l

1.50

35548

147586

(3029937) Albumin [Presence] in Urine by Test strip

11551

45002

1.56

305.53

4.4

3.5

0.00

estimate

1.40

4154

14923

(3019150) Specific gravity of Urine by Refractometry

9544

35701

1.61

298.46

4.2

3.5

1.02

kg/l

0.17

1285

5846

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6399

21520

1.75

298.34

2.6

2.7

22.62

23.11

1.75

5493

18626

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4595

14029

1.90

291.31

2.4

2.3

0.22

0.21

g/l

2.27

4191

13232

(36660697) Celiac disease serology panel - Serum

4164

12299

1.96

290.57

1.2

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

8328

30398

1.63

285.65

4.1

3.4

233.71

718.27

ng/l

20.27

6086

23487

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3630

10280

2.03

284.09

2.1

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2992

7882

2.17

281.42

2.0

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5498

17988

1.78

279.77

2.8

2.9

7.70

9.32

umol/l

5.74

4668

16042

(3011397) Hemoglobin [Presence] in Urine by Test strip

10078

38707

1.57

279.03

3.9

3.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

15750

66580

1.47

278.13

4.2

3.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4959

15772

1.83

276.36

1.8

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

9079

34139

1.59

274.40

2.0

1.8

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1590

3114

2.89

273.76

2.1

1.8

197.86

197.67

pmol/l

0.02

1489

2988

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

37871

191004

1.66

271.25

5.1

4.5

2.78

2.80

mmol/l

4.02

34890

178059

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4960

15865

1.82

271.10

1.9

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

5574

18505

1.76

269.24

1.9

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3295

9234

2.05

264.37

3.0

3.7

4.47

4.54

pmol/l

3.11

2877

8445

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7616

27676

1.63

263.18

2.9

2.7

1.00

1.06

e6/l

0.64

4197

15923

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3570

10340

1.98

261.86

1.7

1.6

—

(3013512) EKG study

11884

47896

1.50

261.20

4.1

3.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1748

3740

2.64

256.30

1.5

1.4

277.79

262.44

ug/g

1.47

986

2239

(3023183) Ammonium ion [Moles/volume] in Plasma

1271

2267

3.16

254.99

3.2

2.5

34.07

34.63

umol/l

0.23

1150

2072

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

424

253

9.33

254.54

1.0

37.02

29.06

ng/l

3.28

290

163

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

423

253

9.31

253.57

1.0

806.81

865.31

ng/l

0.85

283

163

(3009343) pH of Capillary blood

3222

9134

2.02

250.15

3.4

3.5

7.41

7.42

0.80

437

1116

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

420

254

9.20

250.06

1.0

271.57

440.50

ng/l

0.54

290

168

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3251

9255

2.01

249.53

3.4

3.6

5.19

5.09

kpa

9.40

3075

8762

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

404

233

9.65

247.57

1.9

1.3

154.42

76.45

umol/l

2.98

226

107

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1463

2914

2.83

244.30

1.3

507.86

560.26

mg/l

1.65

1380

2804

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2036

4814

2.40

243.99

1.9

1.6

38.69

42.16

nmol/l

7.59

1976

4700

(1002224) Polysomnography panel

2395

6092

2.24

243.86

1.1

1.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3110

8824

2.02

240.55

3.4

3.5

1.58

mmol/l

0.00

2325

6427

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

37230

188221

1.58

239.13

4.6

4.1

4.66

4.70

mmol/l

8.74

34481

176464

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

5669

19543

1.69

237.21

7.5

6.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1321

2529

2.94

236.07

1.4

1.5

1037.82

2060.60

e6/l

0.59

1081

2042

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1319

2528

2.94

235.26

1.4

1.5

20.70

41.69

e6/l

1.59

1017

1955

(3017143) Hepatitis C virus Ab [Presence] in Serum

5841

20385

1.67

233.14

1.7

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

7072

25954

1.60

231.40

3.0

2.8

2.82

2.52

e6/l

1.14

3684

14300

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

36941

186844

1.55

228.85

4.6

4.0

1.42

1.46

mmol/l

78.94

34028

174497

(3021387) Prolactin [Units/volume] in Serum or Plasma

2040

4998

2.31

225.90

1.7

1.6

286.21

289.14

mu/l

0.09

1822

4632

(3019225) pH of Specimen

4526

14877

1.76

223.20

4.1

4.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

4093

13079

1.80

221.69

6.7

7.6

1.38

1.32

mmol/l

3.09

3970

12790

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

35777

180295

1.50

214.92

4.1

3.7

1.39

1.26

mmol/l

149.01

32663

167439

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1284

2556

2.83

214.36

1.2

1.3

3.78

3.70

mmol/l

1.74

1192

2412

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6753

24939

1.58

213.41

2.0

2.2

29.67

29.91

2.43

6551

24240

(3009214) Lutropin [Units/volume] in Serum or Plasma

1869

4569

2.31

207.66

1.4

8.88

9.83

u/l

2.02

1494

3806

(4200892) Spirometry reversibility

3611

11315

1.83

207.60

1.5

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2777

8055

1.96

200.85

1.1

1.0

—

(3025941) Bacteria identified in Stool by Culture

2981

8905

1.91

197.97

1.3

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

13027

55835

1.41

194.92

2.5

2.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3741

12115

1.77

192.45

4.0

1.23

mmol/l

0.86

3199

10786

(3002032) Base excess in Venous blood by calculation

4178

14053

1.71

188.15

4.1

1.82

1.80

mmol/l

0.16

3589

11971

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1831

4639

2.23

187.15

2.2

2.5

550.30

608.04

ug/l

0.16

1705

4373

(3042936) Bacteria identified in Isolate by Culture

6224

23208

1.56

186.15

2.2

1.9

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4177

14089

1.70

186.10

4.1

5.89

5.81

kpa

5.90

4012

13737

(3022313) Gas panel - Capillary blood

2370

6697

2.01

183.83

3.5

3.7

—

(3012544) pH of Venous blood

4297

14681

1.68

182.45

4.1

7.38

0.13

104

(3044290) Cell count panel - Cerebral spinal fluid

1190

2489

2.68

181.42

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2110

5756

2.07

179.62

3.7

3.8

24.89

24.70

mmol/l

2.09

1962

5352

(3000494) Fungus identified in Specimen by Culture

5309

19224

1.60

179.30

1.5

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2703

8093

1.90

177.66

1.8

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

18739

86172

1.35

176.63

2.6

2.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

4908

17512

1.61

175.78

7.4

7.6

11.92

12.93

kpa

30.73

4706

16705

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4909

17517

1.61

175.76

7.4

7.6

5.12

5.06

kpa

3.53

4710

16711

(3000991) Gas panel - Venous blood

3880

13035

1.70

174.79

8.0

8.9

—

(3022145) Colonoscopy Study observation

5187

18905

1.58

169.75

1.3

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3838

12964

1.69

169.24

2.5

2.2

6.78

8.42

ug/l

3.47

3206

11630

(3003396) Base excess in Arterial blood by calculation

4873

17525

1.60

168.50

7.4

7.6

0.98

0.88

mmol/l

0.92

3942

13921

(3026493) Urate [Moles/volume] in Serum or Plasma

10980

46606

1.40

168.45

2.6

2.7

2881.42

4890.11

umol/l

7.05

9438

41602

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2400

7054

1.93

166.24

4.0

4.7

24.13

24.04

mmol/l

0.59

2324

6935

(3005719) IgG [Mass/volume] in Serum or Plasma

3675

12362

1.70

164.28

2.5

2.9

10.43

10.71

g/l

2.82

3321

11428

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

10053

42243

1.41

162.38

2.4

2.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

3166

10255

1.76

161.50

1.3

249.27

254.17

u/ml

0.07

2903

9543

(3024354) Oxygen [Partial pressure] in Venous blood

3432

11382

1.72

161.29

3.5

3.2

4.70

4.62

kpa

1.04

3284

11058

(3023323) Follitropin [Units/volume] in Serum or Plasma

2302

6744

1.93

160.83

1.4

1.3

24.85

29.08

iu/l

6.91

1944

5894

(3013139) Helicobacter pylori Ag [Presence] in Stool

3208

10482

1.74

158.71

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2155

6199

1.97

158.55

1.1

19.79

6.61

u/ml

0.55

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3284

10814

1.73

158.11

1.2

129.25

160.10

iu/ml

3.19

1180

4222

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

10697

45626

1.39

157.42

1.7

1.6

1.49

1.32

mmol/l

52.39

8970

38429

(3041096) Erythrocytes [Presence] in Urine by Automated

11047

47395

1.38

156.85

3.5

2.9

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3329

11031

1.72

156.72

2.4

2.3

22.81

22.93

au/ml

0.02

199

940

(3027945) Reticulocytes/100 erythrocytes in Blood

4796

17503

1.57

155.04

2.5

2.7

1.79

1.72

4.04

4165

15776

(3012516) Albumin [Mass/volume] in Urine

11697

50786

1.37

153.70

3.4

3.3

394.87

382.22

mg/l

0.10

7568

32700

(3003327) Ova and parasites identified in Stool by Light microscopy

1847

5104

2.04

151.51

1.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

454

550

4.59

151.38

3.2

2.7

343.00

364.72

umol/l

1.56

372

435

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3059

10006

1.74

150.46

1.3

41.55

56.96

au/ml

2.63

110

566

(3014765) Yersinia sp identified in Stool by Organism specific culture

1601

4212

2.14

148.94

1.2

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2934

9527

1.75

147.92

6.7

7.6

24.81

24.65

mmol/l

1.32

2903

9460

(42529406) Shigella sp [Presence] in Stool by Culture

1600

4226

2.13

147.37

1.2

1.1

—

(3016502) Oxygen saturation in Arterial blood

4360

15760

1.58

146.22

7.8

8.0

95.36

95.91

6.06

4228

15118

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2049

5956

1.94

146.10

1.3

1.2

0.61

0.89

u/ml

0.66

172

487

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1581

4176

2.13

145.58

1.2

1.1

—

(3003181) Sodium [Moles/volume] in Urine

935

1935

2.70

145.21

1.5

1.3

60.62

64.92

mmol/l

1.99

724

1586

(3020961) Endomysium IgA Ab [Titer] in Serum

2433

7521

1.83

144.12

1.1

142.61

206.73

titre

0.84

251

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2647

8429

1.78

142.36

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

12156

53615

1.35

141.96

4.0

3.9

9.90

8.98

mg/mmol

1.02

7674

34480

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3324

11312

1.67

141.37

3.7

4.3

89.55

94.43

ng/l

1.68

2844

9945

(40761536) Microorganisms panel - Urine sediment

3955

14075

1.60

141.20

4.4

3.5

—

(40761535) Cells panel - Urine sediment

3642

12792

1.62

136.89

3.6

3.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4352

16188

1.54

127.75

3.8

2.9

—

(3019060) Gas panel - Arterial blood

2883

9716

1.68

126.61

5.1

4.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1892

5652

1.89

124.12

1.6

1.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2850

9645

1.67

123.11

1.8

1.9

1.35

1.30

g/l

0.44

2588

8878

(3020891) Body temperature

1882

5640

1.88

122.26

5.3

4.6

—

(40768804) Tissue Pathology biopsy report

15887

74048

1.29

119.38

2.1

2.0

—

(3010421) pH of Blood

1387

3770

2.06

118.46

4.1

3.6

7.42

2.77

1270

3483

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

745

1525

2.72

118.02

1.5

1.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3959

14700

1.53

116.52

8.3

8.4

123.21

121.56

g/l

4.81

3867

14263

(3000492) Spirometry study

4574

17594

1.48

113.79

1.5

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

991

2413

2.30

110.44

1.4

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1366

3810

2.01

108.84

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3877

14583

1.51

107.00

7.7

8.2

8.95

10.13

mmol/l

20.80

3681

13914

(3020630) Protein [Mass/volume] in Serum or Plasma

3506

12905

1.54

106.84

2.3

2.7

66.79

66.59

g/l

0.75

3134

11935

(3023410) Appearance of Cerebral spinal fluid

614

1194

2.86

106.57

1.6

1.7

—

(3012501) Base excess in Blood by calculation

1223

3311

2.07

105.45

4.2

3.6

2.34

2.44

mmol/l

0.56

847

2179

(3013290) Carbon dioxide [Partial pressure] in Blood

1223

3312

2.07

105.37

4.2

3.7

5.02

4.94

kpa

2.82

1191

3245

(3004716) Salmonella sp identified in Stool by Organism specific culture

2516

8579

1.66

105.11

1.3

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

858

2007

2.39

104.40

1.4

1.3

25.33

28.01

u/l

1.28

672

1721

(3027315) Oxygen [Partial pressure] in Blood

1227

3342

2.06

104.13

4.2

3.7

8.77

8.69

kpa

0.81

1195

3275

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2770

9714

1.61

103.59

9.0

9.5

1.47

1.28

15.42

2765

9640

(3004588) Protein electrophoresis panel - Serum or Plasma

2915

10352

1.59

103.53

2.2

2.5

—

(1616796) Gas panel - Central venous blood

1186

3212

2.07

102.15

3.7

3.5

—

(3023520) Reticulocytes [#/volume] in Blood

3495

13008

1.52

101.02

2.6

2.8

72.03

68.65

e9/l

5.35

2564

9861

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2754

9720

1.60

100.23

9.2

9.6

0.68

0.66

0.81

2747

9660

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

6969

29594

1.36

98.16

1.6

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

643

1355

2.64

96.53

1.6

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

345

487

3.93

96.19

1.3

1.2

140.39

135.70

nmol/l

0.79

345

487

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1087

2932

2.07

94.58

1.3

—

(3008898) HLA-B27 [Presence]

1746

5534

1.77

94.52

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1086

2930

2.07

94.43

1.3

—

(3008295) Osmolality of Serum or Plasma

557

1106

2.80

93.25

1.6

1.5

277.78

280.89

mosm/kgh2o

1.95

406

902

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2376

8233

1.63

92.93

8.9

10.0

24.17

24.20

mmol/l

0.17

2292

8016

(3018405) Lactate [Moles/volume] in Arterial blood

1596

4951

1.81

92.70

4.6

4.0

1.37

mmol/l

0.01

1582

4848

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1232

3520

1.96

91.72

1.9

1.6

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

682

1521

2.50

91.66

1.3

1.2

36.30

28.82

nmol/l

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1826

5932

1.73

90.79

2.4

2.3

6554.11

5980.01

u/l

0.25

645

2722

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2042

6866

1.67

89.61

3.2

2.8

1.41

1.15

17.77

2034

6827

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3550

13633

1.48

87.71

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

1426

4373

1.83

85.87

1.2

1.3

83.79

136.32

titre

2.10

132

416

(40767503) Oxygen content in Capillary blood by calculation

1098

3101

1.98

84.42

2.6

2.4

16.69

16.48

0.75

569

1601

(3002179) Metamyelocytes/100 leukocytes in Blood

3413

13124

1.47

83.59

3.6

4.1

0.59

0.69

1.45

1045

4308

(3017181) Myelocytes/100 leukocytes in Blood

3701

14483

1.45

82.79

3.7

4.2

0.87

0.98

1.30

1180

5026

(3017732) Neutrophils [#/volume] in Blood

3083

11644

1.50

82.45

2.5

4.85

4.86

e9/l

0.02

2386

9577

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2588

9431

1.55

81.64

8.0

7.0

24.66

24.44

mmol/l

2.17

2487

8912

(3021440) Promyelocytes/100 leukocytes in Blood

3548

13808

1.45

81.63

3.8

4.3

0.11

0.12

0.27

1035

4383

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

516

1058

2.71

81.58

2.0

2.3

19.52

18.57

nmol/l

1.12

472

1016

(3025159) Blasts/100 leukocytes in Blood

3382

13052

1.47

81.22

3.8

4.3

0.06

0.45

5.59

872

3704

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

703

1687

2.32

80.94

1.6

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5083

21114

1.37

80.77

4.6

4.3

31.18

32.37

11.09

3592

14793

(3034770) Mitochondria Ab [Titer] in Serum

1396

4335

1.80

80.71

1.2

685.41

1116.20

titre

1.92

137

(3028271) Lactate [Moles/volume] in Capillary blood

850

2217

2.14

80.51

1.9

1.7

1.78

1.71

mmol/l

1.04

829

2152

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1536

4935

1.74

79.23

1.8

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1228

3683

1.86

79.21

2.9

3.1

24.68

24.44

mmol/l

1.20

1203

3604

(3052851) Hemolysis interference index of Serum or Plasma

1472

4673

1.76

79.10

3.3

3.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2291

8182

1.57

78.83

2.5

2.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

4598

19003

1.37

74.97

1.8

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

777

2033

2.13

73.04

1.4

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1537

5070

1.70

72.16

1.7

1.20

1.17

g/l

4.28

1461

4836

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4704

19631

1.36

71.97

3.8

4.8

234.01

249.04

u/l

8.04

4400

18762

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1110

3324

1.86

71.92

1.4

—

(3016038) Potassium [Moles/volume] in Urine

389

731

2.95

71.71

1.3

1.2

33.12

36.75

mmol/l

1.92

320

655

(3028626) Oxygen [Partial pressure] in Capillary blood

1142

3458

1.84

71.50

2.9

3.0

8.41

8.35

kpa

0.54

1119

3380

(3004119) Hemoglobin [Mass/volume] in Venous blood

2514

9376

1.51

71.05

3.7

3.4

130.68

128.95

g/l

3.16

2441

9174

(3035637) Corticotropin [Mass/volume] in Plasma

712

1820

2.18

70.87

1.5

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1491

4921

1.70

69.84

1.7

0.24

0.23

g/l

0.48

1414

4670

(3003338) MCHC [Mass/volume]

32215

167486

1.23

69.12

20.4

14.4

332.96

332.92

g/l

0.29

31961

166186

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1379

4476

1.72

68.57

1.1

4.12

6.59

u/ml

1.48

168

597

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2009

7203

1.56

67.77

1.9

2.1

40.30

39.37

u/l

1.11

1784

6419

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

545

1277

2.37

66.17

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

691

1818

2.11

64.10

2.0

1.9

4796.28

3273.49

titre

0.35

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1355

4463

1.70

63.91

1.3

26.03

40.71

u/ml

1.53

289

(3022806) Fractional oxyhemoglobin in Capillary blood

683

1803

2.11

62.83

1.9

1.7

89.59

90.15

1.53

670

1772

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1474

4995

1.65

62.50

2.3

2.5

0.79

0.93

g/l

0.69

1241

4356

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3427

13893

1.39

62.11

2.6

68.73

65.16

ml/min/173m2

4.96

1412

5286

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1123

3542

1.77

61.61

2.3

2.1

132.12

130.65

g/l

0.97

807

2544

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1318

4356

1.69

61.38

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1639

5752

1.59

60.43

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4800

20611

1.32

59.89

1.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2280

8628

1.48

59.82

1.7

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1596

5581

1.60

59.72

2.1

2.4

2.90

2.95

g/l

1.32

1393

5089

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

504

1197

2.34

59.48

1.7

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

753

2107

1.99

59.43

1.3

0.14

0.28

nmol/l

2.20

126

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1029

3202

1.79

59.04

1.2

32.86

47.09

u/ml

1.87

331

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1344

4529

1.66

58.20

2.2

2.3

37.93

37.63

g/l

0.90

1137

4026

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

747

2117

1.96

56.92

1.3

0.63

1.82

nmol/l

0.98

720

2047

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1993

7440

1.50

55.79

1.4

1.6

10.56

15.26

u/ml

0.75

257

(3016244) Insulin [Units/volume] in Serum or Plasma

392

853

2.55

55.52

3.4

3.1

34.02

23.95

mu/l

2.88

368

802

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1667

5995

1.56

55.34

2.1

2.3

7.33

7.40

g/l

0.79

1465

5501

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

466

1104

2.34

55.33

1.2

1.1

40.82

49.70

mg/l

2.02

390

949

(3045414) Leukocytes [Presence] in Urine

1968

7341

1.50

55.28

1.9

1.8

—

(3021901) Oxygen saturation in Capillary blood

892

2711

1.83

55.22

2.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

383

827

2.57

55.07

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1664

5991

1.55

54.97

2.1

2.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1553

5508

1.58

54.74

1.3

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1658

5983

1.55

54.22

2.1

2.3

3.71

3.72

g/l

0.09

1461

5490

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

452

1067

2.35

54.10

1.1

266.99

291.75

mg/l

0.88

390

955

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1383

4792

1.61

53.68

1.4

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1781

6556

1.52

53.22

2.1

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1640

5945

1.54

52.54

1.9

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1951

7345

1.49

52.38

1.7

1.8

1.51

1.52

g/l

0.08

1671

6290

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3208

13231

1.36

51.96

2.8

168.51

210.70

ng/l

5.53

2892

12051

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

942

2969

1.77

51.82

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1607

5829

1.54

51.33

1.6

310.71

287.15

titre

0.11

247

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1230

4186

1.64

51.26

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

433

1029

2.34

51.11

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

674

1919

1.95

50.73

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1289

4453

1.62

50.63

2.2

2.3

0.02

0.03

g/l

0.09

1159

4120

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1548

5594

1.55

50.27

2.2

2.3

9.92

10.33

g/l

2.86

1339

5060

(3024928) Oxygen saturation in Venous blood

981

3165

1.73

49.81

3.4

3.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

6201

28118

1.25

49.66

1.5

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1222

4202

1.62

48.90

1.3

8.02

9.12

u/ml

0.20

187

688

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1812

6818

1.49

48.73

4.3

3.8

50.43

47.08

6.31

1794

6746

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1198

4109

1.63

48.43

2.3

0.00

g/l

0.03

1070

3787

(3027273) Bicarbonate [Moles/volume] in Venous blood

1954

7486

1.46

48.01

3.9

3.4

25.34

25.22

mmol/l

0.81

1891

7274

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1204

4151

1.62

47.68

1.3

4.61

7.39

u/ml

0.58

108

461

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

639

1827

1.94

47.55

1.3

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

337

738

2.53

47.22

1.1

1.62

8.32

nmol/l

2.35

161

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

332

722

2.55

47.16

1.4

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1768

6665

1.48

47.10

1.7

1.6

3.57

3.89

mg/l

0.70

1414

4493

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

638

1841

1.93

46.25

2.1

2.0

27.05

28.25

mg/l

0.18

172

473

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1342

4784

1.57

46.25

1.9

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1669

6241

1.49

46.25

2.1

2.0

2.10

2.44

ug/l

0.46

1454

5614

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

895

2875

1.73

46.16

3.1

3.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

661

1938

1.90

45.74

1.4

1.5

—

(3014271) Vancomycin [Susceptibility]

277

557

2.76

45.62

3.2

2.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

45.60

1.4

0.0

539.78

—

nmol/l

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1173

4063

1.61

45.59

2.3

0.00

g/l

-0.00

1066

3780

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

670

1986

1.87

44.87

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

853

2732

1.74

44.46

1.5

1.6

0.71

0.84

g/l

2.59

636

2065

(3005988) Vibrio sp identified in Specimen by Organism specific culture

649

1912

1.89

44.28

1.4

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

728

2230

1.81

44.03

1.5

1.4

0.34

0.44

nmol/l

1.54

564

1767

(3011985) Renin [Units/volume] in Plasma

704

2135

1.83

43.95

1.6

86.45

58.80

mu/l

1.46

617

1933

(3025468) Yersinia sp identified in Specimen by Organism specific culture

647

1911

1.88

43.81

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

647

1912

1.88

43.74

1.4

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

655

1945

1.87

43.64

1.4

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1136

3952

1.60

43.38

1.8

1.9

12.37

15.82

iu/l

0.13

386

1507

(3017315) Amylase [Enzymatic activity/volume] in Urine

331

756

2.43

42.63

1.4

1.2

300.21

383.67

u/l

0.54

309

707

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

279

585

2.64

42.58

1.2

1.3

68.48

66.59

0.11

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

396

982

2.24

42.56

1.3

1.2

2.00

2.14

mmol/l

1.56

364

913

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

253

504

2.78

42.42

2.6

2.3

55.45

49.22

umol/l

2.22

214

442

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

715

2215

1.79

41.71

1.1

1.49

1.50

g/l

0.27

644

2015

(3037121) Protein [Mass/volume] in Urine

1524

5722

1.49

41.38

3.0

3.4

0.28

0.34

g/l

1.73

650

2703

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1009

3462

1.62

40.75

1.1

1.99

2.41

u/ml

0.56

514

1765

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

656

1995

1.83

40.63

1.3

1.4

306.83

409.31

pmol/l

0.79

565

1748

(3016650) Hepatitis A virus Ab [Presence] in Serum

804

2629

1.70

38.99

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

261

556

2.60

38.71

1.8

1.7

1.96

1.99

umol/l

0.15

242

521

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

192

343

3.10

38.71

1.2

18.20

20.51

0.14

(3023419) Bacteria identified in Sputum by Culture

723

2299

1.75

38.69

2.5

2.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

330

791

2.31

38.37

1.1

1.03

1.11

u/l

0.85

136

372

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

205

384

2.95

38.27

2.9

28.35

28.51

umol/l

0.06

156

308

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1001

3485

1.60

38.13

1.2

1.71

6.81

u/ml

2.76

294

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

993

3456

1.60

37.88

1.2

0.60

15.94

u/ml

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

308

722

2.36

37.61

1.3

1.2

4.89

5.12

umol/l

0.40

278

674

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

218

429

2.81

37.42

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

553

1638

1.87

37.21

7.1

6.1

7.36

7.22

mmol/l

0.35

465

1321

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

797

2637

1.68

37.04

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

562

1678

1.86

36.91

1.4

0.38

0.42

g/l

1.99

389

1163

(3027135) IgG subclass 1 [Mass/volume] in Serum

562

1681

1.86

36.71

1.4

6.57

6.99

g/l

1.64

388

1166

(3028192) IgG subclass 2 [Mass/volume] in Serum

561

1678

1.86

36.64

1.4

2.96

3.09

g/l

0.83

386

1165

(40768443) Skin Pathology biopsy report

1904

7628

1.39

36.51

1.2

—

(4062490) Immunoglobulin typing, IgG

561

1681

1.85

36.45

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1271

4720

1.50

36.39

1.9

2.1

10.63

11.00

mg/l

0.86

1181

4413

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

308

734

2.32

36.31

1.3

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

904

3120

1.61

35.70

1.1

5.45

5.81

u/ml

0.24

470

1643

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1049

3758

1.55

35.42

1.2

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

559

1689

1.84

35.40

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4281

19290

1.25

35.29

1.4

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

237

506

2.59

35.06

2.6

2.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

221

457

2.68

34.73

2.1

2.6

0.77

1.10

ug/l

1.59

208

437

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

373

989

2.09

34.18

1.2

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

288

686

2.33

34.03

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

280

659

2.35

33.96

1.6

1.4

18.43

28.53

umol/l

6.96

263

626

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1316

5006

1.46

33.48

3.0

3.5

35.33

47.50

mg/l

2.12

1025

4109

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2158

8949

1.35

33.38

10.0

10.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

859

2978

1.60

33.34

1.1

1.10

1.22

u/ml

0.20

371

1300

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

369

987

2.07

33.08

1.2

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

328

837

2.17

33.08

1.5

5.79

6.11

u/l

0.24

275

704

(3034860) Kappa light chains.free [Mass/volume] in Serum

1315

5015

1.46

33.02

3.0

3.5

51.95

72.82

mg/l

1.01

1024

4110

(3029634) Reagin Ab [Titer] in Serum by VDRL

727

2425

1.67

32.83

2.4

2.1

5.21

6.37

titre

0.19

(3006270) Folate [Moles/volume] in Blood

402

1115

2.00

32.74

1.2

1.1

375.20

358.52

nmol/l

0.77

347

941

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

970

3481

1.55

32.53

1.3

273.91

260.06

u/ml

0.66

616

2251

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1029

3745

1.53

32.40

1.6

1.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

402

1120

1.99

32.35

1.1

282.98

290.97

mg/l

1.07

358

1022

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

761

2582

1.64

32.21

1.1

21.56

12.39

au/ml

0.85

177

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1391

5388

1.44

32.20

1.4

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1276

4864

1.46

32.13

3.0

3.5

11.70

3.80

ratio

0.66

112

383

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1059

3890

1.51

31.96

1.6

1.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1261

4801

1.46

31.95

1.5

18.88

12.86

iu/ml

0.53

116

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

931

3326

1.56

31.85

1.2

1.3

164.44

148.81

titre

0.08

(3022621) pH of Urine by Test strip

2598

11146

1.30

31.71

3.0

2.6

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

240

543

2.45

31.69

1.8

1.7

28.18

29.40

umol/l

0.92

230

526

(3000475) Leukocytes [#/volume] in Synovial fluid

1100

4085

1.50

31.53

1.6

1.7

15058.59

13470.08

e6/l

0.37

790

3020

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

285

702

2.25

31.27

1.1

7.41

10.17

u/ml

0.66

128

(3036489) Thrombin time

1621

6488

1.39

31.23

2.1

2.2

21.62

21.60

0.03

1406

5668

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1016

3719

1.52

31.17

1.2

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

201

423

2.63

30.64

1.5

1.4

14.21

15.85

pmol/l

2.09

163

366

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

289

724

2.21

30.50

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

230

520

2.45

30.44

1.8

1.3

1833040.27

2895208.73

iu/ml

0.31

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1407

5519

1.42

30.42

1.3

220.73

226.96

miu/ml

0.23

588

2667

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

6.07

29.86

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

823

2903

1.58

29.77

1.1

1.83

1.96

u/ml

0.17

431

1427

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1414

5575

1.41

29.71

2.7

2.6

—

(3007463) Buprenorphine [Presence] in Urine

+∞

29.31

7.0

0.0

—

(44813793) Dust mix specific IgE antibody measurement

392

1126

1.93

29.01

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

142

253

3.10

28.89

1.2

—

(21494755) Public health laboratory ask at order entry panel

3360

22605

0.81

28.62

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

715

2468

1.61

28.32

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

148

275

2.98

28.16

1.8

2.0

—

(3014051) Protein [Presence] in Urine by Test strip

1116

4254

1.46

28.13

2.5

2.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3017

20460

0.80

27.61

1.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

283

735

2.13

27.44

2.3

2.2

18.78

38.14

umol/l

1.14

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

788

2808

1.56

27.32

1.7

1.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

796

2847

1.55

27.16

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

254

634

2.22

27.11

1.6

4.67

7.62

nmol/l

0.33

192

546

(3047007) Chlamydophila sp Ab [Presence] in Serum

714

2496

1.59

26.87

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

766

2723

1.56

26.85

3.3

3.2

63.27

66.21

2.93

761

2712

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

153

299

2.83

26.76

1.3

1.2

119.75

118.14

nmol/l

0.03

104

231

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

124

213

3.22

26.74

1.4

1.7

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

6.15

26.63

1.2

1.1

47.83

39.07

mg/l

1.07

(3042631) Mycobacterium sp identified in Specimen

637

2171

1.63

26.58

2.8

2.5

—

(3044941) Cell count panel - Synovial fluid

729

2573

1.57

26.36

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

937

3496

1.49

26.32

2.1

2.0

0.88

0.81

nmol/l

2.04

759

2965

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1418

5719

1.38

26.12

1.6

11.18

6.47

iu/ml

0.18

273

1224

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

713

2511

1.58

26.03

1.3

—

(3021788) Differential panel - Synovial fluid

847

3104

1.52

25.92

1.4

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

623

2126

1.63

25.88

7.2

6.2

11.58

11.48

mg/l

0.21

572

1963

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

349

1005

1.92

25.71

1.2

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

743

2651

1.56

25.65

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

439

1363

1.79

25.64

1.4

1.3

1.39

1.37

nmol/l

0.14

398

1230

(4146454) Self-monitoring of blood glucose

532

1747

1.69

25.58

2.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1165

4564

1.42

25.41

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

686

2408

1.58

25.41

1.4

—

(4034850) Laboratory test

1327

5327

1.39

25.15

10.8

8.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

802

2925

1.52

25.11

1.8

1.9

5.06

5.26

mmol/24h

0.87

710

2614

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

322

910

1.96

25.05

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

633

2190

1.60

24.90

1.5

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

425

1320

1.78

24.82

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.44

24.69

2.0

2.6

17.43

20.65

umol/l

0.87

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

271

725

2.07

24.45

2.0

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

586

2005

1.62

24.13

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

521

1730

1.67

24.08

1.2

60.89

63.73

u/l

0.30

464

1563

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

222

553

2.22

23.88

1.1

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

371

1120

1.83

23.76

2.8

2.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

967

3708

1.45

23.70

1.5

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

686

2458

1.55

23.30

1.1

5.74

3.70

u/ml

0.96

328

1187

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

312

897

1.93

23.16

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

341

1012

1.87

23.04

1.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

603

2102

1.59

23.04

1.2

62.82

53.91

u/ml

0.34

135

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

202

492

2.27

22.91

1.4

1.5

72.07

71.60

0.15

193

475

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

16.01

22.84

1.1

1.0

—

mmol/l

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1197

4801

1.39

22.84

3.5

3.6

1.51

mg/l

0.02

1094

4444

(3027923) C peptide [Moles/volume] in Serum or Plasma

287

806

1.97

22.78

1.6

1.5

1.23

1.21

nmol/l

0.12

213

658

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

378

1164

1.80

22.75

1.1

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

213

533

2.21

22.70

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

135

271

2.75

22.60

1.1

0.72

5.59

umol/24h

0.49

145

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

606

2125

1.58

22.60

1.4

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

198

482

2.27

22.50

1.4

1.5

375.66

976.31

mu/l

1.71

189

465

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

372

1147

1.80

22.31

1.3

1.87

1.96

u/ml

0.05

204

641

(3023430) Cat dander IgE Ab [Units/volume] in Serum

644

2301

1.55

22.17

1.1

6.43

4.28

u/ml

1.06

282

965

(40760888) Immunoglobulin light chains.free panel - Serum

974

3788

1.43

22.16

3.0

3.6

—

(3032057) Clostridioides difficile [Presence] in Stool

127

250

2.81

22.03

1.8

1.7

—

(3002256) Pathology report gross observation

5016

23960

1.18

21.94

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

452

1489

1.68

21.58

4.1

3.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

397

1262

1.74

21.52

2.7

2.5

744.45

646.08

e6/l

1.39

379

1227

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

667

2425

1.53

21.26

1.1

2.37

3.17

u/ml

1.31

286

1203

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

500

1700

1.63

21.18

1.6

1.9

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

118

229

2.85

21.01

1.5

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

631

2275

1.54

20.90

1.5

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

207

533

2.15

20.66

1.5

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

258

724

1.97

20.58

1.2

161.26

159.16

mmol/24h

0.13

258

724

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

305

908

1.86

20.48

1.2

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

1157

4700

1.37

20.46

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

252

704

1.98

20.36

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

252

704

1.98

20.36

1.4

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

749

2825

1.47

20.06

1.1

1161.55

791.18

iu/ml

0.12

187

605

(3049717) Cytology report of Urine Cyto stain

1509

6413

1.31

19.72

2.4

2.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

149

339

2.43

19.68

1.1

—

(3047181) Lactate [Moles/volume] in Blood

1235

5109

1.34

19.45

6.4

5.8

1.36

1.28

mmol/l

1.53

1082

4507

(3038177) Helicobacter pylori Ab [Presence] in Serum

746

2829

1.46

19.45

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

329

1022

1.78

19.34

1.1

6.68

9.07

iu/ml

0.95

270

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

169

411

2.27

19.33

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1233

5118

1.34

19.00

2.5

2.7

189.29

189.73

0.05

1160

4867

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

141

318

2.45

18.98

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

351

1118

1.74

18.97

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

676

2532

1.48

18.77

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

290

877

1.83

18.61

1.5

1.6

8.11

8.64

ug/l

0.18

263

802

(3001186) Copper [Moles/volume] in Serum or Plasma

140

318

2.43

18.58

1.3

1.2

16.72

16.54

umol/l

0.17

123

290

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

329

1035

1.76

18.57

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

569

2060

1.53

18.56

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1285

5392

1.32

18.40

2.6

2.8

3.62

3.59

g/l

0.27

1222

5177

(3039443) Prostate specific Ag panel - Serum or Plasma

512

4262

0.66

18.28

1.5

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

207

561

2.04

18.22

1.9

—

(3017509) Phencyclidine [Presence] in Urine

109

3.60

18.14

1.5

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

957

3848

1.38

18.07

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

151

361

2.31

17.98

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1332

5637

1.31

17.97

2.2

2.5

92.37

91.30

0.89

1275

5430

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

551

1997

1.53

17.91

1.0

0.66

0.40

u/ml

0.54

147

501

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

325

1030

1.75

17.91

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

144

338

2.36

17.86

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

369

1214

1.68

17.81

1.5

—

(3011048) Pyruvate [Moles/volume] in Blood

4.99

17.61

1.4

1.2

91.64

66.46

umol/l

2.65

(3028717) Thiamine [Mass/volume] in Blood

101

3.66

17.56

1.1

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

947

3820

1.38

17.55

1.4

1.5

20.30

21.07

u/ml

0.04

(3037756) Immunofixation for Serum or Plasma

834

3305

1.40

17.19

1.5

1.7

—

(3017569) Oxygen content in Arterial blood

221

628

1.95

17.13

2.2

2.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

649

2458

1.46

17.10

2.6

3.0

212.00

815.25

u/ml

1.18

638

2427

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

436

1514

1.59

17.08

2.9

2.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

410

1404

1.62

17.00

1.6

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

410

1404

1.62

17.00

1.6

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

410

1404

1.62

17.00

1.6

1.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

350

1151

1.68

16.95

1.3

1.4

12.29

12.41

umol/l

0.10

332

1114

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

558

2055

1.50

16.87

1.1

0.82

2.22

iu/ml

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

301

950

1.75

16.86

2.4

2.2

98.08

96.01

0.42

278

887

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2027

13625

0.81

16.82

1.4

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

102

208

2.71

16.74

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

111

237

2.59

16.72

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

171

2.91

16.72

1.3

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

441

1546

1.58

16.62

1.4

1.3

183.33

201.00

pmol/l

0.29

441

1546

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1331

5695

1.30

16.59

3.6

3.2

0.35

0.34

u/ml

0.56

758

3204

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1025

4229

1.35

16.50

2.3

2.4

140.83

103.14

ug/min

1.31

611

2616

(3045424) Erythrocytes [Presence] in Urine

730

2849

1.42

16.43

1.5

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

140

338

2.29

16.37

1.1

—

(3045716) Anion gap in Serum or Plasma

218

627

1.92

16.35

2.2

2.6

10.00

9.79

mmol/l

0.31

213

609

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2028

9145

1.23

16.32

2.9

2.7

0.27

0.28

e6/l

0.10

1972

8909

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

517

1888

1.52

16.29

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

447

1580

1.57

16.28

1.7

1.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

141

343

2.27

16.21

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

133

3.16

16.13

1.1

1.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

702

2730

1.43

16.12

1.6

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

702

2731

1.43

16.09

1.6

1.7

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

133

317

2.32

16.01

1.1

6.69

7.20

mg/g

0.35

126

302

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1536

6730

1.27

15.91

5.7

5.0

1.84

1.62

8.01

1439

6297

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

135

3.11

15.77

1.1

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

591

2240

1.46

15.56

2.0

2.3

7.90

7.20

umol/l

0.22

427

1646

(3004451) EKG impression Narrative

241

729

1.83

15.56

1.3

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

476

1726

1.53

15.52

3.5

3.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

356

1206

1.63

15.46

2.7

2.5

533.82

536.13

e6/l

0.02

296

1015

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

302

979

1.71

15.46

1.2

1.3

101.02

89.68

u/l

0.75

264

862

(3028679) Herpes simplex virus Ab [Presence] in Serum

276

872

1.75

15.46

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

368

1260

1.62

15.33

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

368

1261

1.62

15.28

1.2

—

(3001556) Androgen free Index in Serum or Plasma

138

3.04

15.25

1.3

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

442

1583

1.55

15.24

1.3

1.4

129587.75

93624.00

e6/l

0.47

298

1074

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

368

1262

1.61

15.24

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

499

1837

1.50

15.18

1.6

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

197

2.66

15.17

1.1

1.0

85.99

83.00

ug/l

0.25

151

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

292

945

1.71

15.06

1.2

1.3

26.92

25.09

u/l

0.21

246

822

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

867

3538

1.36

15.03

1.5

113.43

113.05

u/ml

0.03

197

802

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

364

1251

1.61

14.95

1.2

—

(3000012) Reticulocyte production index

591

2259

1.45

14.93

2.2

2.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

363

1248

1.61

14.89

1.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

401

1414

1.57

14.81

1.2

162.00

183.85

titre

0.09

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

363

1250

1.61

14.80

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

402

1419

1.57

14.79

1.2

110.00

205.34

titre

2.26

253

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

441

1591

1.53

14.74

1.4

1.5

29.00

30.97

0.51

263

1029

(3021367) Citalopram [Moles/volume] in Serum or Plasma

+∞

14.66

1.3

0.0

167.45

—

nmol/l

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1498

6615

1.26

14.56

5.8

5.0

0.91

0.89

0.37

1402

6189

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

128

317

2.23

14.20

1.5

1.6

0.39

0.40

ug/l

0.11

206

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1927

8774

1.22

14.16

2.9

3.5

64.80

53.50

u/ml

0.30

1852

8506

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

276

896

1.70

14.11

1.3

266.50

458.95

titre

0.61

(3038026) Centromere Ab [Units/volume] in Serum

382

1350

1.57

14.01

1.2

61.98

42.18

u/ml

0.43

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.66

13.95

2.2

1.8

1.33

1.35

umol/l

0.06

(3013676) Sertraline [Moles/volume] in Serum or Plasma

+∞

13.84

1.1

0.0

149.69

—

nmol/l

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

310

1046

1.64

13.74

1.4

1.5

23.61

24.02

u/ml

0.05

190

(3023420) DNA double strand Ab [Units/volume] in Serum

508

1918

1.47

13.71

1.6

1.5

35.26

33.96

iu/ml

0.04

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

268

872

1.70

13.61

1.3

67.50

83.24

titre

0.29

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

303

1019

1.65

13.61

1.6

7.39

6.81

u/l

0.23

232

840

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

372

1318

1.56

13.52

1.2

79.25

67.18

u/ml

0.28

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

3.51

13.44

1.6

1.3

5.79

16.89

pmol/l

1.03

(3012565) Volume of 24 hour Urine

260

842

1.71

13.44

2.0

2.2

1968.38

1960.25

0.03

236

758

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

338

1174

1.59

13.36

2.8

2.5

0.23

e9/l

0.08

295

1013

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

211

2.49

13.35

1.4

0.30

0.21

nmol/l

0.62

151

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

372

1324

1.56

13.27

1.2

51.59

43.99

u/ml

0.24

107

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

419

1534

1.51

13.16

4.2

5.4

65.13

137.73

u/ml

1.96

121

548

(3051651) Icteric interference index of Serum or Plasma

290

974

1.65

13.12

4.1

4.0

—

(3044927) Protein electrophoresis panel - Urine

413

1510

1.51

13.06

1.2

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

485

1834

1.46

13.02

1.5

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

149

407

2.02

13.01

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

207

633

1.81

13.01

2.2

1.8

—

(3028433) Virus identified in Specimen by Culture

182

534

1.88

13.00

1.2

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

485

1835

1.46

12.99

1.5

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

204

622

1.81

12.94

1.1

—

(3011412) CD3 cells [#/volume] in Blood

458

1716

1.48

12.88

2.7

2.3

1.27

1.16

e9/l

0.86

407

1542

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

341

2856

0.66

12.71

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

663

2665

1.38

12.70

1.3

33.58

36.74

u/l

0.19

570

2331

(3002619) Bacteria identified in Specimen by Culture

118

298

2.19

12.57

1.3

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

303

1043

1.61

12.47

1.8

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

917

3886

1.31

12.39

5.6

6.0

6638.32

1310.94

iu/ml

0.48

116

630

(21494815) CD4 cells/100 lymphocytes in Specimen

422

1569

1.49

12.35

2.4

2.0

38.97

37.22

1.50

415

1540

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3751

18275

1.14

12.30

3.5

4.4

19.45

28.45

ug/l

1.04

3006

14735

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

133

356

2.06

12.28

1.2

296.73

281.90

pmol/l

0.14

266

(3027456) Digoxin [Moles/volume] in Serum or Plasma

673

2732

1.36

12.16

3.2

2.9

0.82

0.81

nmol/l

0.03

495

2112

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

188

571

1.82

12.11

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

476

1821

1.45

12.08

3.2

4.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

140

2.76

12.03

2.9

3.8

41.82

41.19

umol/l

0.08

112

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

352

1267

1.54

12.00

1.2

7.04

11.75

u/ml

0.36

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1611

10712

0.82

12.00

1.4

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

192

589

1.80

11.99

1.1

2927.10

564.28

ng/l

0.73

163

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

560

2213

1.40

11.90

1.5

1.6

60.53

56.91

1.29

352

1481

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

318

1121

1.57

11.88

3.2

3.7

121.05

145.94

nmol/l

0.61

313

1106

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

295

1023

1.60

11.81

2.8

40.77

37.68

2.05

159

564

(3012494) Peanut IgE Ab [Units/volume] in Serum

161

470

1.89

11.73

1.1

2.98

4.81

u/ml

0.44

266

(3012920) Ethanol [Mass/volume] in Serum or Plasma

15.18

11.70

1.3

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

185

567

1.80

11.60

1.2

0.30

0.31

g/l

1.56

145

460

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

704

2904

1.34

11.50

2.7

2.9

636.58

6515.43

u/ml

1.03

173

(3020491) Glucose [Moles/volume] in Blood

344

1247

1.53

11.39

1.7

6.97

6.55

mmol/l

1.54

255

885

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

254

857

1.64

11.37

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

255

864

1.63

11.23

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.16

11.17

1.6

1.8

45.48

52.65

umol/l

0.88

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

507

1998

1.40

10.99

3.1

3.4

5.22

9.24

nmol/l

0.77

486

1942

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

201

2.36

10.97

1.6

1.7

5.17

7.74

nmol/l

0.68

195

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

659

2712

1.35

10.96

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

663

2732

1.34

10.94

1.2

4.16

3.88

u/ml

0.20

286

1278

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

632

2589

1.35

10.84

1.1

119.51

116.60

1.27

572

2353

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

169

515

1.81

10.84

1.2

109.21

113.51

1.15

151

461

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

221

729

1.68

10.80

4.0

3.7

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

240

2.21

10.55

1.8

1.6

45.60

52.62

pmol/l

0.27

199

(37021550) Renin [Units/volume] in Plasma --upright

117

317

2.04

10.54

1.3

58.64

67.62

mu/l

0.25

236

(3019977) pH of Arterial blood

233

786

1.64

10.48

2.7

2.2

7.42

0.12

288

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

132

375

1.95

10.46

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1053

7206

0.80

10.43

1.5

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

136

2.64

10.36

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.71

10.34

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

176

2.42

10.32

1.3

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

227

767

1.64

10.17

1.1

1.2

28.45

17.84

u/ml

0.26

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

167

522

1.77

9.91

1.2

1.1

110.11

104.59

0.91

150

473

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

675

2833

1.32

9.88

1.2

3.62

3.70

u/ml

0.04

223

1031

(3014148) Varicella zoster virus Ab [Titer] in Serum

598

2467

1.34

9.85

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

855

3710

1.28

9.76

1.6

1.5

—

(3024263) Appearance of Synovial fluid

250

875

1.58

9.74

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

279

1004

1.54

9.64

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

122

348

1.94

9.60

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

152

468

1.79

9.50

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

421

1650

1.41

9.50

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

228

786

1.60

9.47

1.1

1624.11

1465.21

miu/ml

1.10

228

786

(3020876) Protein [Mass/time] in 24 hour Urine

467

1866

1.39

9.42

2.4

2.6

1.38

1.35

g/24h

0.07

218

1021

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

160

503

1.76

9.34

1.1

92.00

86.82

0.81

253

(21491868) Cryoglobulin [Mass/volume] in Serum

173

557

1.72

9.31

1.2

0.61

0.49

g/l

0.09

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

162

512

1.75

9.29

1.1

92.42

87.76

1.08

254

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

975

4324

1.25

9.29

1.3

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

291

1066

1.51

9.29

1.0

2.43

2.97

u/ml

0.11

272

(1175426) CD3 cells/100 lymphocytes in Blood

357

1366

1.45

9.19

2.3

2.0

73.91

71.91

1.81

338

1321

(40768800) Prostate Pathology biopsy report

573

4137

0.76

8.91

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

292

1082

1.49

8.85

1.1

1.45

1.77

u/ml

0.14

112

353

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

106

297

1.97

8.81

2.8

62.45

73.66

mg/l

0.14

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

206

706

1.61

8.80

3.0

2.8

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

5.52

8.76

2.0

1.4

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

132

2.51

8.75

1.0

2.31

2.21

u/ml

0.02

111

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

716

5000

0.79

8.56

1.8

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

237

2.07

8.49

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

535

2229

1.33

8.33

1.6

1.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

212

746

1.57

8.16

1.6

1.7

134.48

146.33

1.59

195

699

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

236

853

1.53

8.09

1.2

1.1

85.59

84.35

u/l

0.08

210

786

(40761539) Cells [Type] in Urine sediment by Light microscopy

123

374

1.82

8.08

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

154

501

1.70

8.06

1.6

1.5

—

(3039000) Anion gap in Blood

819

3626

1.25

7.99

7.9

6.9

11.41

11.17

mmol/l

1.10

737

3245

(3018572) Chloride [Moles/volume] in Blood

819

3627

1.25

7.97

7.9

6.9

104.60

105.37

mmol/l

4.55

737

3247

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

208

733

1.57

7.97

2.3

2.4

23.70

382.67

ug/l

1.71

197

704

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

221

2.07

7.95

1.0

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

165

552

1.65

7.81

1.6

1.8

158.50

173.05

0.88

153

522

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

137

2.38

7.76

1.0

0.35

1.80

u/ml

0.53

113

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.70

7.76

1.1

1.2

15.26

13.81

nmol/l

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

167

562

1.64

7.73

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

234

854

1.51

7.70

1.2

1.1

23.67

23.91

u/l

0.02

210

783

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

114

2.52

7.69

1.7

1.6

2.65

1.85

mg/l

0.42

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

232

2.02

7.65

1.1

1.3

34.21

45.78

mg/l

1.55

199

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

324

1263

1.42

7.64

2.4

2.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

227

825

1.52

7.62

2.3

2.1

102.63

78.36

ug/min

0.28

184

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1242

5767

1.19

7.61

1.5

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

2.76

7.54

1.2

1.5

41.08

29.56

0.72

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

277

1054

1.45

7.45

1.1

1.2

1.07

ratio

0.00

104

373

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

342

1353

1.40

7.44

2.3

2.0

13.96

15.72

2.73

335

1320

(3033799) Differential panel - Peritoneal fluid

144

471

1.69

7.43

2.2

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

288

1106

1.44

7.39

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

202

2.08

7.35

1.6

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

127

2.39

7.34

1.2

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

2.83

7.34

1.0

0.10

1.34

u/ml

0.91

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

255

1.95

7.34

1.1

2.32

3.94

u/ml

0.53

194

(3002523) Influenza virus A Ag [Presence] in Specimen

672

2939

1.27

7.32

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

111

338

1.81

7.31

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

671

2938

1.26

7.25

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

163

556

1.62

7.20

3.3

3.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

313

1227

1.41

7.19

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

184

648

1.57

7.13

2.5

2.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

190

2.09

7.10

1.3

45.22

60.50

1.39

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

205

2.05

7.09

2.5

2.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

900

5998

0.82

7.02

1.4

1.5

—

(3010503) CD19 cells [#/volume] in Blood

283

1095

1.43

7.00

2.9

2.5

0.28

0.45

e9/l

0.61

269

1071

(3035947) Staphylolysin Ab [Units/volume] in Serum

220

810

1.50

7.00

1.2

1.1

3.17

3.67

iu/ml

0.49

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

184

652

1.56

6.96

2.2

2.0

28.84

29.76

0.41

177

618

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

189

674

1.55

6.95

2.7

160.04

140.20

au/ml

0.17

(3006245) CD3-CD19+ cells/100 cells in Blood

186

661

1.56

6.95

2.4

2.1

9.52

11.11

0.95

179

610

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

151

511

1.63

6.90

1.1

1.0

13.08

13.05

u/ml

0.00

306

(40768441) Liver Pathology biopsy report

327

1303

1.39

6.86

1.5

1.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.61

6.84

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

836

5596

0.82

6.84

1.4

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

8787

51183

0.93

6.84

4.1

21.53

22.10

2.57

3709

24624

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

270

1.88

6.81

5.3

5.1

48.76

44.26

ug/min

0.20

223

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

164

2.16

6.80

2.2

2.5

1.02

1.55

mmol/l

0.83

119

(3051593) INR in Capillary blood by Coagulation assay

197

713

1.53

6.80

5.3

13.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

146

493

1.64

6.74

1.3

1.4

53.64

56.53

0.38

120

424

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

208

764

1.50

6.71

1.0

1.1

98.55

95.57

0.64

168

607

(3030313) Adrenal Ab [Titer] in Serum

133

2.28

6.69

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

835

5576

0.82

6.67

1.4

1.5

—

(3051339) Copper [Moles/volume] in Blood

2.99

6.64

1.1

1.2

17.05

16.29

umol/l

0.28

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

130

2.29

6.63

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

141

2.23

6.59

1.0

0.03

0.21

u/ml

1.10

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

110

2.41

6.55

1.6

1.5

1.85

3.05

mg/l

0.75

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

110

2.41

6.55

1.6

1.5

1.28

0.77

mg/l

0.46

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

110

2.41

6.55

1.6

1.5

3.44

4.21

mg/l

0.28

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

110

2.41

6.55

1.6

1.5

1.53

1.65

mg/l

0.05

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

110

2.41

6.55

1.6

1.5

2.41

2.03

mg/l

0.19

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

110

2.41

6.55

1.6

1.5

2.43

1.42

mg/l

1.14

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

110

2.41

6.55

1.6

1.5

3.21

1.57

mg/l

0.93

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

110

2.41

6.55

1.6

1.5

2.02

2.61

mg/l

0.23

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

110

2.41

6.55

1.2

1.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

110

2.41

6.55

1.6

1.5

2.18

1.41

mg/l

0.45

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

262

1.88

6.55

1.2

1.3

70.49

111.78

ng/l

0.66

194

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.20

6.50

1.3

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

210

779

1.49

6.48

1.1

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

267

1.86

6.48

1.1

2.47

9.59

pmol/l

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

842

5599

0.83

6.45

1.4

1.5

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

2.69

6.42

1.2

1.6

11.50

14.05

0.22

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

844

5604

0.83

6.37

1.4

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

147

2.18

6.36

1.9

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

163

576

1.56

6.29

2.1

1.8

3612.09

3687.66

e6/l

0.01

103

397

(3002331) Protein [Mass/volume] in Peritoneal fluid

108

343

1.74

6.26

1.4

1.3

22.86

43.73

g/l

0.71

281

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

853

3905

1.21

6.18

1.4

124.50

135.38

pmol/l

0.24

830

3816

(3017354) Segmented neutrophils/100 leukocytes in Blood

406

1704

1.32

6.15

2.8

3.6

55.61

56.82

0.52

344

1459

(3015076) Soybean IgE Ab [Units/volume] in Serum

249

970

1.42

6.01

1.0

0.66

0.45

u/ml

0.42

244

(3000060) B lymphocytes [#/volume] in Blood

140

483

1.60

5.99

2.3

2.0

1042.05

605.68

e6/l

0.20

236

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

122

407

1.66

5.96

2.7

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

122

407

1.66

5.96

2.7

2.2

—

(3005033) Fetal Nuchal fold Thickness US

675

4547

0.82

5.95

1.4

1.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

215

817

1.45

5.93

1.4

1.5

2.69

4.83

1.33

205

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

236

1.87

5.90

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

197

739

1.47

5.81

3.3

7.88

7.91

mg/l

0.02

149

602

(3043238) Trisomy 21 risk [Likelihood] in Fetus

693

4641

0.82

5.77

1.4

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

680

4561

0.82

5.76

1.4

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

453

1949

1.29

5.75

1.1

96.40

95.38

0.32

425

1836

(40768793) Breast Pathology biopsy report

786

3598

1.21

5.73

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

290

1171

1.37

5.71

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

192

1.96

5.70

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

125

2.21

5.70

2.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

275

1.79

5.70

2.4

6.81

7.78

mmol/l

1.37

160

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

177

2.00

5.68

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

284

1.77

5.64

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

638

2865

1.23

5.63

2.8

3.5

1.51

1.58

0.19

574

2571

(3000330) Specific gravity of Urine by Test strip

1779

8706

1.13

5.57

3.6

3.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.58

5.51

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

237

932

1.41

5.47

8.4

5.0

669.49

1993.86

u/ml

0.66

151

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

146

2.08

5.44

1.1

1.73

4.29

umol/24h

0.52

146

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.64

5.44

1.2

1.4

0.44

2.06

1.50

(21494890) Protein electrophoresis panel - 24 hour Urine

404

1727

1.29

5.41

1.9

2.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

802

3703

1.20

5.37

3.0

3.6

862.04

989.49

u/ml

0.12

724

3392

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

143

511

1.55

5.33

2.1

1.7

10354.96

12250.67

e6/l

0.10

275

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

6396

37360

0.94

5.29

2.9

0.67

0.80

ug/l

13.33

4230

23865

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

106

354

1.65

5.21

1.1

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

2.48

5.13

1.9

1.5

192.76

181.94

ug/g

0.14

(3027231) Wheat IgE Ab [Units/volume] in Serum

327

1.67

5.08

1.1

1.0

0.66

3.48

u/ml

0.59

297

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

2.53

5.04

1.0

15.88

22.41

u/ml

0.26

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

149

546

1.51

4.99

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

432

1884

1.27

4.99

2.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

103

346

1.64

4.98

1.3

1.2

85.91

89.78

0.24

119

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.01

4.96

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

112

385

1.61

4.95

1.4

1.2

11.43

14.46

g/l

2.50

306

(3016031) Almond IgE Ab [Units/volume] in Serum

2.33

4.93

1.0

1.1

0.67

0.61

u/ml

0.04

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

626

4164

0.83

4.93

1.4

1.5

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

+∞

4.88

1.0

0.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

180

689

1.44

4.87

2.0

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

180

689

1.44

4.87

2.0

2.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

825

5349

0.85

4.85

1.5

1.6

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.44

4.84

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

182

699

1.44

4.84

2.0

2.2

—

(3015183) Erythrocyte sedimentation rate

226

903

1.38

4.82

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

131

471

1.54

4.80

1.6

1.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

104

354

1.62

4.79

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

363

1558

1.29

4.78

3.1

3.0

42.99

59.97

mg/l

0.82

271

1113

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

170

1.92

4.74

1.0

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

106

365

1.60

4.68

1.2

1.4

111.82

105.77

1.19

343

(3036670) Protein [Mass/volume] in Synovial fluid

135

493

1.51

4.63

1.3

39.75

41.40

g/l

0.67

273

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

668

3079

1.20

4.63

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

141

2.00

4.60

1.0

0.22

1.11

u/ml

0.73

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

137

503

1.50

4.59

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

184

1.86

4.58

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

241

1.74

4.55

1.2

0.99

0.43

u/ml

0.35

235

(4035726) Immunohistochemistry procedure

3176

16200

1.09

4.55

1.4

—

(3016750) Collection duration of Urine

256

1057

1.34

4.48

2.3

513.23

495.15

min

2.56

197

813

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.37

4.45

1.3

1.4

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

198

1.81

4.45

1.8

1.7

1.92

1.80

mg/l

0.26

165

(3044007) Cell count panel - Peritoneal fluid

128

467

1.51

4.43

2.3

1.8

—

(3026250) Tacrolimus [Mass/volume] in Blood

223

903

1.36

4.43

35.6

35.4

7.35

7.34

ug/l

0.03

202

822

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

101

349

1.60

4.42

1.3

1.2

77.11

77.60

0.02

118

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

241

1764

0.75

4.40

1.5

1.6

7.93

7.58

mmol/l

1.47

225

1685

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

223

905

1.36

4.37

1.9

2.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

210

844

1.37

4.37

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

223

906

1.36

4.34

1.9

2.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

190

753

1.39

4.30

4.8

6.5

2145.19

2124.02

mg/l

0.00

141

542

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

145

1.94

4.29

1.0

1.16

0.76

u/ml

0.16

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

386

1695

1.26

4.28

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

163

630

1.43

4.25

2.0

1.5

68542.13

23519.50

u/ml

0.36

(3010375) cycloSPORINE [Mass/volume] in Blood

217

882

1.36

4.23

28.3

28.4

112.54

116.27

ug/l

0.35

174

755

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

333

1.59

4.16

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

333

1.59

4.16

1.1

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

105

2.10

4.16

1.1

7.67

10.05

u/l

0.41

105

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

192

768

1.38

4.14

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.90

4.12

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

334

1.59

4.12

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

479

2165

1.22

4.11

1.8

2.0

28.30

24.88

ug/l

0.32

471

2124

(3003694) ABO and Rh group [Type] in Blood

10570

56228

1.05

4.09

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

215

1580

0.75

4.08

1.5

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

+∞

4.07

1.2

0.0

24.82

—

nmol/l

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

2.20

4.04

1.0

0.26

0.85

u/ml

0.65

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

122

451

1.49

4.01

1.6

8.88

9.10

ug/l

0.26

122

451

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.42

3.97

1.3

1.5

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.83

3.97

1.0

289.82

169.13

pmol/l

1.71

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.26

3.96

1.2

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.24

3.95

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

154

1.86

3.92

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

112

2.02

3.88

1.1

1.2

144.64

124.78

ug/l

0.28

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

188

1.76

3.81

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.25

3.80

1.1

40.35

43.82

u/l

0.17

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

209

1.72

3.78

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

210

1.71

3.73

1.0

0.25

u/ml

0.00

145

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

126

1.93

3.68

1.1

—

(3017400) Magnesium [Moles/volume] in Urine

3.51

3.65

1.0

1.1

2.36

2.91

mmol/l

—

(3036603) Volume of Urine

287

1243

1.28

3.64

1.4

1.6

1982.86

1928.71

0.44

281

1205

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

5.06

3.61

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.12

3.54

1.5

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

156

1.80

3.52

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.17

3.51

1.1

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

139

543

1.41

3.50

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.13

3.47

1.1

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

138

1055

0.72

3.47

1.3

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

137

1.85

3.46

1.0

0.73

0.49

u/ml

0.15

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

223

942

1.31

3.44

1.6

1.7

2.22

2.93

u/field

0.67

159

675

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

207

1.68

3.43

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.18

3.43

1.3

3.3

3.22

2.19

mu/l

0.28

(3024316) Viscosity of Plasma

2.14

3.41

2.2

1.9

1.85

1.66

mpas

0.38

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.58

3.40

1.2

1.3

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.34

3.36

1.1

1.3

0.69

1.02

umol/24h

0.20

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

198

826

1.32

3.35

1.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

198

826

1.32

3.35

1.4

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

327

1.52

3.29

1.1

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

152

1.78

3.26

1.3

341.64

503.13

mg/24h

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

303

1342

1.25

3.23

1.8

1.6

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.09

3.23

1.2

1.1

1.04

1.23

u/field

0.61

(3042733) HLA Ab [Presence] in Serum

169

693

1.35

3.22

4.4

5.2

—

(40762365) Oxygen content in Arterial blood by calculation

250

1.59

3.20

4.6

3.0

14.68

14.69

ml/dl

0.00

238

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

420

1928

1.20

3.18

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

272

1193

1.26

3.17

1.5

1.4

12.33

12.75

u/l

0.51

264

1154

(3016228) CD19 cells/100 cells in Blood

178

738

1.33

3.16

2.3

1.9

9.54

8.29

0.72

168

725

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

128

504

1.40

3.13

1.1

1.2

—

(3000285) Sodium [Moles/volume] in Blood

213

1.63

3.12

1.2

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.26

3.08

4.3

3.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

462

0.61

3.07

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

144

582

1.37

3.03

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.96

2.95

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

250

1100

1.26

2.87

6.1

6.9

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.40

2.87

1.2

—

(3017704) Immunofixation for Urine

207

891

1.28

2.85

1.4

1.7

—

(3006462) Nitrate [Presence] in Urine

190

809

1.30

2.84

3.2

3.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

193

1.63

2.84

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

147

604

1.34

2.82

5.9

6.8

24.35

25.02

mmol/l

1.04

136

544

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.90

2.79

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

180

764

1.30

2.77

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

2.86

2.75

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

187

799

1.29

2.74

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

3.57

2.73

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

108

1.84

2.71

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

257

1.53

2.70

1.6

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

300

1359

1.22

2.67

1.9

1.8

3.98

3.91

mg/l

0.08

285

1305

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

336

1541

1.20

2.65

3.8

44.77

61.01

u/ml

0.59

330

1523

(3009015) Lactate [Moles/volume] in Synovial fluid

172

1.64

2.61

1.2

1.3

4.83

6.77

mmol/l

1.94

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

126

1.75

2.60

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

807

3964

1.13

2.60

4.1

2.9

25.96

27.64

mg/l

0.53

475

2576

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1296

6531

1.10

2.59

3.3

3.7

353.75

1807.24

u/ml

2.54

1092

5674

(21494814) CD8 cells/100 lymphocytes in Specimen

170

726

1.29

2.53

2.3

1.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

239

1.52

2.53

1.1

—

(3042628) Porphyrins [Moles/volume] in Urine

6.62

2.52

1.2

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

163

1.63

2.42

1.0

1.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.00

2.41

1.2

1.39

1.36

0.25

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.88

2.39

1.5

1.3

19.00

59.37

e6/l

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

361

1.41

2.39

5.1

6.5

64.61

73.06

2.00

292

(3049233) Organic acids panel - Urine

4.83

2.39

1.1

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

168

1.61

2.38

1.1

1.2

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

1.91

2.38

1.0

1.3

—

12392.83

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

157

670

1.29

2.38

2.0

9.29

9.75

mg/l

0.44

126

537

(3013466) aPTT in Blood by Coagulation assay

1.84

2.37

1.0

1.1

35.46

38.62

1.77

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.01

2.34

1.1

829.42

370.03

u/l

0.37

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.80

2.31

1.5

1.3

24.84

13.99

pmol/l

0.54

(3037692) Legionella sp identified in Specimen by Organism specific culture

153

655

1.29

2.28

1.6

1.4

—

(40757373) Influenza virus identified in Isolate

310

1.42

2.25

1.6

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

239

1.48

2.18

1.6

1.4

6.09

221747.50

nmol/l

1.40

207

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.84

2.17

1.1

1.5

22.39

21.21

mmol/l

0.65

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

364

1.38

2.15

1.2

1.1

57.38

66.46

u/ml

0.53

352

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.23

2.15

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

121

507

1.32

2.13

1.4

1.3

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

139

1.63

2.11

2.3

3.6

1.98

2.29

mg/l

0.47

120

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.76

2.11

1.3

1.4

2836.62

1283.00

u/l

0.31

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.86

2.10

1.0

0.17

0.14

u/ml

0.09

(3050794) Legionella sp Ab [Presence] in Serum

157

1.58

2.08

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.76

2.04

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.76

2.04

1.0

7.00

8.32

u/ml

0.10

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

111

1.69

2.02

1.4

1.2

35.37

22.72

—

(3034426) Prothrombin time (PT)

142

614

1.28

2.00

1.2

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.73

1.99

1.4

1.7

0.65

0.66

umol/l

0.04

(3044009) aPTT.lupus sensitive (LA screen)

159

1.56

1.99

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

112

470

1.32

1.98

1.6

1.3

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

5.52

1.96

1.0

13.20

14.80

umol/l

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

5.52

1.96

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

108

1.69

1.96

1.1

—

(40768446) Kidney Pathology biopsy report

178

794

1.24

1.94

1.5

1.7

—

(3019174) dRVVT (LA screen)

147

1.58

1.94

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

283

1.40

1.92

1.3

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

291

1365

1.18

1.90

1.9

1.8

1.86

2.25

u/field

0.53

136

586

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

215

1.46

1.89

1.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.84

1.89

1.7

1.6

0.00

0.05

u/l

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.45

1.85

1.0

5.20

0.36

u/ml

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

123

529

1.28

1.84

1.6

1.7

140.50

132.75

au/ml

0.05

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.77

1.83

1.5

1.8

181.60

198.50

ng/l

0.67

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.94

1.82

1.0

0.04

0.25

u/ml

—

(3025577) Chromium [Mass/volume] in Blood

228

1053

1.20

1.79

2.0

2.1

1.99

2.46

ug/l

1.79

189

893

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

292

1.38

1.78

1.1

1.3

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

116

1.62

1.76

1.2

1.1

28.84

25.79

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

116

1.62

1.76

1.2

1.1

17.46

35.10

u/ml

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

398

1.32

1.74

1.2

1.3

—

(40759632) Porphyrins [Mass/mass] in Stool

3.22

1.74

1.4

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

289

1367

1.17

1.73

2.1

1.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

183

1.48

1.73

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

399

1.31

1.71

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

399

1.31

1.71

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

399

1.31

1.71

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

399

1.31

1.71

1.2

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

211

1.44

1.70

1.4

1.6

102.01

115.90

ug/l

0.41

175

(3018834) Bilirubin.total [Presence] in Urine by Test strip

107

0.46

1.70

1.1

3.5

—

0.00

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

132

580

1.26

1.69

2.2

1.8

—

(3018133) Calcium [Moles/volume] in Urine

267

1.39

1.69

1.7

2.0

2.60

2.73

mmol/l

0.20

237

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.24

1.69

1.1

1.69

3.28

1.67

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.15

1.65

7.4

5.3

0.23

0.27

mmol/l

0.17

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

131

577

1.25

1.65

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

278

1.37

1.64

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

204

1.43

1.63

1.2

1.4

24.52

24.33

0.01

159

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

221

1031

1.18

1.59

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

209

1364

0.84

1.59

1.2

1.3

1.50

1.54

g/l

1.38

209

1364

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

147

0.53

1.59

1.1

1.4

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

404

1.30

1.59

2.0

2.6

106.17

108.35

ng/l

0.06

213

(1761868) Lipid panel - Serum or Plasma

12867

72283

0.98

1.58

2.8

2.6

—

(3026470) Cobalt [Mass/volume] in Blood

231

1084

1.18

1.56

2.0

2.86

4.00

ug/l

2.18

208

996

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

295

1.35

1.56

1.2

1.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.33

1.56

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

103

1.61

1.54

1.8

1.4

—

(40762887) Creatinine [Moles/volume] in Blood

2.21

1.52

1.2

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

364

1.30

1.51

2.3

2.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

181

835

1.20

1.50

1.1

1.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

2.76

1.49

1.0

5.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

629

0.78

1.49

2.8

3.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

186

1.42

1.45

1.3

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

101

1.58

1.43

2.6

1.9

12.54

16.22

0.25

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

169

779

1.20

1.43

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.71

1.43

1.0

0.20

0.05

u/ml

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

124

1.51

1.39

1.0

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.67

1.38

1.3

1.2

25.08

22.29

u/ml

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.61

1.38

1.1

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.60

1.35

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

503

2516

1.10

1.34

1.3

3.60

4.06

ug/l

0.27

444

2239

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.75

1.33

1.1

1.2

1.25

0.87

u/field

1.14

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.77

1.32

1.2

1571.31

4300.24

ng/l

0.86

(3041672) Baker's yeast Ab [Presence] in Serum

1.60

1.31

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

135

1.47

1.31

2.6

2.0

59.32

62.97

0.21

(3015350) Toxocara sp Ab [Presence] in Serum

2.45

1.31

1.0

—

(36303858) Crystals [Presence] in Urine

2.45

1.31

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

126

1.49

1.31

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

281

1.32

1.29

1.7

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

550

2770

1.10

1.29

1.3

7.09

7.06

mmol/l

0.08

487

2422

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

450

2244

1.11

1.28

2.4

2.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

100

1.55

1.27

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

300

1464

1.13

1.25

2.4

706.56

676.93

0.54

227

1019

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.32

1.25

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.32

1.25

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.32

1.25

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.32

1.25

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.32

1.25

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.32

1.25

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

123

1.48

1.24

2.6

3.0

39.60

511.55

pmol/l

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.88

1.24

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

151

1.43

1.22

2.6

2.4

2.84

3.34

mg/l

0.52

144

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.61

1.22

1.1

1.0

—

(3022689) Creatine [Moles/volume] in Urine

119

541

1.21

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

126

577

1.21

1.19

1.5

1.4

59.80

62.71

0.41

107

471

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.76

1.17

1.2

1.1

34.98

34.78

nmol/24h

—

(3047189) Immunofixation for 24 hour Urine

162

761

1.18

1.16

1.8

1.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

424

2122

1.10

1.16

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

139

1.43

1.16

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

106

479

1.22

1.15

1.8

2.1

27.07

35.15

u/l

0.43

442

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

103

1.50

1.14

5.6

4.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

771

3965

1.07

1.13

1.8

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

793

4680

0.93

1.09

4.8

3.6

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.84

1.09

1.2

1.1

0.07

0.05

g/l

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.96

1.08

1.4

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.07

1.07

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

105

479

1.21

1.06

1.3

39.84

37.89

0.20

334

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

199

1.33

1.05

3.5

2.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

137

642

1.18

1.04

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.99

1.04

1.0

1.1

1274.44

2670.80

titre

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

501

0.80

1.04

1.2

1.3

—

(3009677) Dengue virus Ab [Presence] in Serum

1.57

1.04

1.0

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

166

1.36

1.04

1.1

—

(3024932) HLA-DR beta [Type]

148

699

1.17

1.03

1.0

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

316

1573

1.11

1.00

1.4

6.76

6.19

mmol/l

2.29

291

1472

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

201

1.32

0.99

3.5

2.8

22.15

22.50

mg/l

0.06

188

(40761995) Spermatozoa Progressive [#/volume] in Semen

100

660

0.84

0.98

3.5

3.2

—

(3013862) HLA-DP [Type]

0.54

0.98

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

100

659

0.84

0.97

7.0

6.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.64

0.94

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.79

0.94

1.1

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

122

1.40

0.94

1.0

0.26

1.02

u/ml

0.49

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

416

1.21

0.93

2.9

2.5

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

2.01

0.92

1.1

70.06

70.95

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

137

1.37

0.91

1.1

1.0

5.22

20.19

iu/ml

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

137

1.37

0.91

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.48

0.90

1.0

—

(3022670) pH of Venous cord blood

1.92

0.89

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

181

1.31

0.88

1.8

2.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

155

746

1.15

0.88

1.1

1.3

—

(40763590) HLA-DQ beta [Type]

0.57

0.87

1.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

148

1.34

0.86

1.4

1.26

1.72

ml/s/173m2

0.32

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.58

0.84

1.1

277.19

264.73

nmol/l

0.12

(3024471) HLA-A [Type]

148

714

1.14

0.83

1.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.83

0.0

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.77

0.82

1.1

—

(3034614) HLA Ag [Interpretation]

1.70

0.81

1.6

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.45

0.80

1.0

1.59

19.23

u/ml

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.41

0.80

1.4

1.6

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

239

1.25

0.78

2.4

2.6

90.10

73.15

pmol/l

0.15

210

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

1.41

0.77

1.0

1.3

—

438.57

—

(3014891) Appearance of Pleural fluid

200

1.27

0.77

1.4

1.2

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

113

1.37

0.77

1.6

1.7

0.86

0.57

0.51

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.93

0.76

1.1

—

(3032641) Amino acids panel - Urine

2.12

0.75

1.6

1.3

—

(40762814) Titanium [Mass/volume] in Blood

316

1.21

0.74

2.4

2.3

4.07

4.18

ug/l

0.04

101

(3006969) Lambda light chains [Mass/volume] in Urine

1.69

0.74

1.1

0.04

0.02

g/l

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

307

1.20

0.72

3.7

2.8

2838.29

1490.85

u/l

0.40

273

(3007919) Fasciola sp Ab [Titer] in Serum

1.72

0.72

1.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

516

2675

1.07

0.70

3.4

3.5

26.03

40.37

u/ml

3.35

503

2583

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

130

1.32

0.69

4.7

5.3

—

(3001729) Color of Synovial fluid

135

1.31

0.68

1.6

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.68

0.68

4.6

3.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

204

1.24

0.68

2.7

—

(3006598) pH of Arterial cord blood

1.67

0.66

1.1

—

(46236302) HLA-C [Type] by High resolution typing

0.63

1.0

—

(40760410) HLA-B [Type] by High resolution

0.63

1.0

—

(40760409) HLA-A [Type] by High resolution

0.63

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

257

1.20

0.62

2.5

2.1

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.62

0.0

1.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.59

0.60

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.40

0.59

12.5

8.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

11451

63806

0.99

0.57

4.5

4.8

2.23

3.30

ug/l

6.70

10133

57974

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.63

0.57

1.0

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.66

0.56

1.7

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

293

0.83

0.56

6.5

1.2

7.77

7.30

mmol/l

0.37

(40768806) Pleura Pathology biopsy report

342

1770

1.07

0.54

1.5

1.6

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.58

0.54

3.0

2.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

181

1.22

0.53

1.0

1.1

21.53

19.63

u/l

0.21

119

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

212

1080

1.08

0.52

2.0

2.1

—

(3045142) Bone marrow Pathology biopsy report

352

2062

0.94

0.51

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

248

1.18

0.51

1.1

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

214

1092

1.08

0.51

1.4

5.76

5.54

mmol/l

2.18

199

1033

(3012441) Differential panel - Pleural fluid

338

1754

1.06

0.50

1.6

1.5

—

(3027874) Urate [Moles/volume] in Urine

1.38

0.50

1.1

1.32

10.83

mmol/l

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.48

0.48

7.7

9.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

327

1.15

0.47

1.3

1.1

0.76

33.81

mg/l

1.15

239

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

286

1.16

0.47

2.6

2.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

170

864

1.09

0.46

2.9

3.5

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.31

0.45

1.0

2.18

15.77

u/ml

0.41

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.47

0.44

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

326

0.86

0.44

5.5

5.7

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.62

0.43

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.42

0.0

1.0

—

(3003577) Lead [Moles/volume] in Blood

151

1.21

0.42

1.4

1.5

0.28

0.20

umol/l

0.50

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.75

0.41

1.2

1.1

—

(3041184) Isoniazid [Presence] in Urine

1.45

0.40

2.0

2.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

188

1.17

0.39

1.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

112

1.23

0.39

1.4

1.2

275.84

328.71

umol/24h

0.98

112

(3011335) Digoxin [Mass/volume] in Serum or Plasma

133

1.20

0.37

2.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

345

1.12

0.37

4.6

5.5

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.30

0.37

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.29

0.37

1.2

1.1

0.07

0.06

g/l

0.30

(3048879) Bone marrow aspiration report

106

535

1.09

0.36

1.8

1.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

108

1.23

0.36

2.1

1.8

—

(3013727) Leukocytes other/100 leukocytes in Blood

124

631

1.08

0.36

3.2

3.5

51.86

52.37

0.09

124

601

(1617658) Protocol used for examination of sentinel lymph nodes

232

1208

1.06

0.36

1.1

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

124

0.80

0.35

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

712

3808

1.03

0.34

3.7

2.9

1.57

1.56

mmol/l

0.14

697

3734

(3020618) Glucose [Moles/volume] in Synovial fluid

1.31

0.34

1.0

1.1

5.91

5.48

mmol/l

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.32

0.33

3.0

4.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

264

1.13

0.33

1.5

1.4

10.93

12.51

0.16

136

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

348

1838

1.05

0.33

1.3

1.4

9.14

8.04

mmol/l

3.94

338

1774

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.33

0.31

1.0

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

102

519

1.08

0.31

1.5

1.4

3.05

2.33

0.55

429

(3033705) Calcium.ionized [Moles/volume] in Venous blood

393

2085

1.04

0.31

2.8

2.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

407

0.91

0.30

1.5

1.4

31.70

22.31

1.43

337

(40758292) HTLV I+II Ab panel - Serum

343

0.90

0.29

1.4

—

(3013762) Body weight Measured

1.24

0.28

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

174

1.14

0.28

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

112

1.18

0.28

4.0

3.4

32.88

10.55

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

102

1.19

0.27

1.5

1.6

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.67

0.27

1.6

2.3

8.36

18.46

ng/l

—

(3008607) Semen analysis panel

185

1.13

0.27

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.24

0.25

1.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.31

0.25

1.3

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

379

2023

1.03

0.24

1.6

1.5

2843.02

2225.02

e6/l

0.45

281

1448

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.38

0.24

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

140

1.14

0.23

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.31

0.23

1.4

1.2

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.22

0.0

1.2

—

2.57

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.22

0.0

1.0

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.2

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.20

0.22

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

347

0.92

0.21

5.9

7.1

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.21

0.0

1.3

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.6

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

461

1.07

0.20

1.6

1.4

24.32

19.96

0.74

408

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

370

1.07

0.20

2.0

1.6

1.55

4.57

ug/l

1.40

233

(3003434) Protein [Mass/volume] in Pleural fluid

423

2272

1.03

0.20

1.6

1.5

33.83

33.22

g/l

0.42

390

2045

(3005593) Pancreatic islet cell Ab [Titer] in Serum

1.23

0.20

1.3

1.0

—

(40765096) Chromosome analysis panel by Banding

545

0.94

0.20

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

1.16

0.20

1.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

289

1544

1.03

0.20

1.4

1.3

514.43

466.67

u/l

0.20

271

1472

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

259

0.92

0.19

7.7

8.9

0.36

0.33

umol/l

0.24

237

(3028308) Erythrocytes [#/volume] in Pleural fluid

344

1849

1.03

0.17

1.6

1.5

67166.41

44156.73

e6/l

0.55

216

1076

(4212803) Bone marrow aspirate examination

144

1.11

0.17

1.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.21

0.16

1.1

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

257

1377

1.03

0.16

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

528

0.95

0.16

1.4

1.3

4.42

3.36

mmol/l

1.41

498

(3041918) Cholesterol [Moles/volume] in Pleural fluid

311

1.06

0.15

1.2

1.55

1.70

mmol/l

0.45

196

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

227

0.92

0.15

1.3

1.2

147.60

372.34

u/l

0.49

161

(4281824) Cell count and differential, peritoneal fluid

357

1926

1.02

0.15

1.2

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.82

0.14

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

238

1.07

0.12

6.3

4.9

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

454

1.05

0.12

1.3

143.27

227.43

ug/l

0.38

241

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

225

0.93

0.12

1.2

1.5

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.88

0.12

1.0

9.29

8.61

0.26

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.88

0.12

1.2

—

(3035880) pH of Pleural fluid

175

938

1.03

0.12

1.4

1.3

—

(3045788) Cell count panel - Pleural fluid

291

1571

1.02

0.12

1.6

1.5

—

(40768795) Lymph node Pathology biopsy report

335

1886

0.98

0.12

1.2

—

(3022475) Manganese [Moles/volume] in Blood

110

1.10

0.12

1.1

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

124

662

1.03

0.11

1.8

1.6

—

(21494434) Karyotype in Bone marrow

278

1566

0.98

0.11

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

183

1036

0.97

0.11

1.3

1.4

29.34

32.91

nmol/l

0.85

157

972

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.89

0.10

5.4

12.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

447

0.96

0.09

5.9

8.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

154

0.93

0.09

2.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

209

1.06

0.09

2.3

0.68

0.56

u/field

0.27

209

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.15

0.08

3.0

2.2

—

(40758358) Immune stain study

1.10

0.08

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.10

0.08

1.1

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

225

1219

1.02

0.08

1.3

12.72

13.74

u/l

0.45

214

1129

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.07

0.08

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

102

1.08

0.07

3.6

3.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

505

0.97

0.07

5.9

8.3

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.08

0.07

1.0

1.1

0.68

0.91

u/ml

0.12

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1351

7492

0.99

0.06

1.9

1.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

114

1.06

0.06

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

196

1.04

0.05

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

158

1.05

0.05

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

257

1.03

0.04

1.2

1.3

0.98

1.58

mmol/l

0.63

166

(3042111) Morphology [Interpretation] in Bone marrow Narrative

526

2884

1.01

0.04

1.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

116

1.05

0.03

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.06

0.02

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

274

0.99

0.00

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

659

3640

1.00

0.00

3.9

3.0

7.38

7.51

mmol/l

0.59

644

3578

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.00

0.00

1.1

1.4

1.20

1.06

u/field

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.04

0.00

3.2

2.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

136

1.01

0.00

2.6

5.2

—

(3010937) Rubella virus Ab [Presence] in Serum

108

0.97

0.00

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.97

0.00

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

203

1.01

0.00

3.2

2.9

1.26

1.39

mg/l

0.19

130

(3003157) Bacteria [#/volume] in Mother's milk

0.97

0.00

5.0

6.5

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.89

0.00

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.92

-0.00

1.2

2.02

2.21

mmol/24h

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.94

-0.00

3.6

3.5

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.97

-0.00

2.0

2.2

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

-0.00

0.0

5.2

—

(3025311) HLA-B [Type]

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: F5_DEPRESSION_DYSTHYMIA – Depression or dysthymia

GWS hits: 79

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Depression or dysthymia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Depression or dysthymia (F5_DEPRESSION_DYSTHYMIA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints